BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Malhi GS, Bassett D, Boyce P, Bryant R, Fitzgerald PB, Fritz K, Hopwood M, Lyndon B, Mulder R, Murray G, Porter R, Singh AB. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry 2015;49:1087-206. [DOI: 10.1177/0004867415617657] [Cited by in Crossref: 414] [Cited by in F6Publishing: 334] [Article Influence: 59.1] [Reference Citation Analysis]
Number Citing Articles
1 Jones H, Geddes J, Cipriani A. Lithium and Suicide Prevention. In: Malhi GS, Masson M, Bellivier F, editors. The Science and Practice of Lithium Therapy. Cham: Springer International Publishing; 2017. pp. 223-40. [DOI: 10.1007/978-3-319-45923-3_13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
2 Morey-Nase C, Phillips LJ, Bryce S, Hetrick S, Wright AL, Caruana E, Allott K. Subjective experiences of neurocognitive functioning in young people with major depression. BMC Psychiatry 2019;19:209. [PMID: 31272419 DOI: 10.1186/s12888-019-2197-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
3 Malhi GS, Porter R. Mood disorders are categorically dimensional! Aust N Z J Psychiatry 2016;50:1038-9. [DOI: 10.1177/0004867416676606] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
4 Katsikitis M, Lane BR, Ozols I, Statham D. Consumer and carer perspectives in the development of a mental health research, treatment and teaching facility: A thematic analysis. J Psychiatr Ment Health Nurs 2017;24:534-44. [DOI: 10.1111/jpm.12394] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
5 Malhi GS, Byrow Y. Is treatment-resistant depression a useful concept? Evid Based Ment Health. 2016;19:1-3. [PMID: 26767390 DOI: 10.1136/eb-2015-102299] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
6 Kato T, Ishigooka J, Miyajima M, Watabe K, Fujimori T, Masuda T, Higuchi T, Vieta E. Double-blind, placebo-controlled study of lurasidone monotherapy for the treatment of bipolar I depression. Psychiatry Clin Neurosci 2020;74:635-44. [PMID: 32827348 DOI: 10.1111/pcn.13137] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
7 Malhi GS, Bell E, Singh AB, Bassett D, Berk M, Boyce P, Bryant R, Gitlin M, Hamilton A, Hazell P, Hopwood M, Lyndon B, McIntyre RS, Morris G, Mulder R, Porter R, Yatham LN, Young A, Murray G. The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders: Major depression summary.Bipolar Disord. 2020;22:788-804. [PMID: 33320412 DOI: 10.1111/bdi.13035] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
8 Armour M, Smith CA, Wang LQ, Naidoo D, Yang GY, MacPherson H, Lee MS, Hay P. Acupuncture for Depression: A Systematic Review and Meta-Analysis. J Clin Med. 2019;8. [PMID: 31370200 DOI: 10.3390/jcm8081140] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
9 Rourke K, Wilson CJ. How adolescents perceive that community-based exercise improves their well-being. Australas Psychiatry 2017;25:456-9. [PMID: 28880109 DOI: 10.1177/1039856217726718] [Reference Citation Analysis]
10 Kishi T, Sakuma K, Okuya M, Matsuda Y, Esumi S, Hashimoto Y, Hatano M, Miyake N, Miura I, Miyahara K, Fujita K, Kawashima K, Mishima K, Iwata N. Recurrence of Mania or Depression Among Adult Bipolar Patients Who Continued Using Lithium: A Single-group Summary Meta-analysis of Randomized Trials. J Clin Psychopharmacol 2020;40:468-74. [DOI: 10.1097/jcp.0000000000001264] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Shrestha N, Pedisic Z, Jurakic D, Biddle SJH, Parker A. Physical activity and sedentary behaviour counselling: Attitudes and practices of mental health professionals. PLoS One 2021;16:e0254684. [PMID: 34270611 DOI: 10.1371/journal.pone.0254684] [Reference Citation Analysis]
12 Schubert KO, Wisdom A. Should the Australian Therapeutic Goods Administration recommend rapid dosing of lithium carbonate in acute mania? Aust N Z J Psychiatry 2018;52:387. [PMID: 29216733 DOI: 10.1177/0004867417746000] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
13 Fisher A, Sharpe L, Anderson J, Manicavasagar V, Juraskova I. Development and pilot of a decision-aid for patients with bipolar II disorder and their families making decisions about treatment options to prevent relapse. PLoS One 2018;13:e0200490. [PMID: 29990368 DOI: 10.1371/journal.pone.0200490] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
14 Amare AT, Schubert KO, Hou L, Clark SR, Papiol S, Heilbronner U, Degenhardt F, Tekola-Ayele F, Hsu YH, Shekhtman T, Adli M, Akula N, Akiyama K, Ardau R, Arias B, Aubry JM, Backlund L, Bhattacharjee AK, Bellivier F, Benabarre A, Bengesser S, Biernacka JM, Birner A, Brichant-Petitjean C, Cervantes P, Chen HC, Chillotti C, Cichon S, Cruceanu C, Czerski PM, Dalkner N, Dayer A, Del Zompo M, DePaulo JR, Étain B, Falkai P, Forstner AJ, Frisen L, Frye MA, Fullerton JM, Gard S, Garnham JS, Goes FS, Grigoroiu-Serbanescu M, Grof P, Hashimoto R, Hauser J, Herms S, Hoffmann P, Hofmann A, Jamain S, Jiménez E, Kahn JP, Kassem L, Kuo PH, Kato T, Kelsoe J, Kittel-Schneider S, Kliwicki S, König B, Kusumi I, Laje G, Landén M, Lavebratt C, Leboyer M, Leckband SG, Tortorella A, Manchia M, Martinsson L, McCarthy MJ, McElroy S, Colom F, Mitjans M, Mondimore FM, Monteleone P, Nievergelt CM, Nöthen MM, Novák T, O'Donovan C, Ozaki N, Ösby U, Pfennig A, Potash JB, Reif A, Reininghaus E, Rouleau GA, Rybakowski JK, Schalling M, Schofield PR, Schweizer BW, Severino G, Shilling PD, Shimoda K, Simhandl C, Slaney CM, Squassina A, Stamm T, Stopkova P, Maj M, Turecki G, Vieta E, Volkert J, Witt S, Wright A, Zandi PP, Mitchell PB, Bauer M, Alda M, Rietschel M, McMahon FJ, Schulze TG, Baune BT; International Consortium on Lithium Genetics (ConLi+Gen). Association of Polygenic Score for Schizophrenia and HLA Antigen and Inflammation Genes With Response to Lithium in Bipolar Affective Disorder: A Genome-Wide Association Study. JAMA Psychiatry 2018;75:65-74. [PMID: 29121268 DOI: 10.1001/jamapsychiatry.2017.3433] [Cited by in Crossref: 17] [Cited by in F6Publishing: 38] [Article Influence: 5.7] [Reference Citation Analysis]
15 Kim JM, Kim HY, Lee HJ, Kim JW, Kang HJ, Kim SW, Shin IS, Chun BJ, Stewart R. Prediction of Suicidality According to Serum Folate Levels in Depressive Patients Receiving Stepwise Pharmacotherapy. Front Psychiatry 2021;12:747228. [PMID: 34925091 DOI: 10.3389/fpsyt.2021.747228] [Reference Citation Analysis]
16 Malhi GS, Bell E, Bassett D, Boyce P, Hopwood M, Murray G, Porter R, Singh A, Mulder R. Virtual guidance: Mood disorders guidelines '2. Oh'! Aust N Z J Psychiatry 2021;:48674211010244. [PMID: 33938288 DOI: 10.1177/00048674211010244] [Reference Citation Analysis]
17 Fourrier C, Sampson E, Mills NT, Baune BT. Anti-inflammatory treatment of depression: study protocol for a randomised controlled trial of vortioxetine augmented with celecoxib or placebo. Trials 2018;19:447. [PMID: 30126458 DOI: 10.1186/s13063-018-2829-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
18 Parikh RB, Gallo JJ, Wong YN, Robinson KW, Cashy JP, Narayan V, Jayadevappa R, Chhatre S. Long-term depression incidence and associated mortality among African American and White prostate cancer survivors. Cancer 2021;127:3476-85. [PMID: 34061986 DOI: 10.1002/cncr.33656] [Reference Citation Analysis]
19 Sinniah A, Oei T, Maniam T, Subramaniam P. Positive effects of Individual Cognitive Behavior Therapy for patients with unipolar mood disorders with suicidal ideation in Malaysia: A randomised controlled trial. Psychiatry Research 2017;254:179-89. [DOI: 10.1016/j.psychres.2017.04.026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
20 Wang D, Osser DN. The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An update on bipolar depression. Bipolar Disord 2020;22:472-89. [DOI: 10.1111/bdi.12860] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
21 Hopwood M. The Shared Decision-Making Process in the Pharmacological Management of Depression. Patient 2020;13:23-30. [PMID: 31544218 DOI: 10.1007/s40271-019-00383-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
22 Laing T, Sheen J, Nicola-richmond K, Pépin G, O’shea M. The utility of threshold concepts for clinical psychology education programmes. Clinical Psychologist 2021;25:316-28. [DOI: 10.1080/13284207.2021.1949244] [Reference Citation Analysis]
23 Munkholm K, Winkelbeiner S, Homan P. Individual response to antidepressants for depression in adults-a meta-analysis and simulation study. PLoS One 2020;15:e0237950. [PMID: 32853222 DOI: 10.1371/journal.pone.0237950] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
24 Murray G. What Would Digital Early Intervention for Bipolar Disorder Look Like? Theoretical and Translational Considerations for Future Therapies. Front Psychiatry 2019;10:599. [PMID: 31507467 DOI: 10.3389/fpsyt.2019.00599] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
25 O'Neil A, Russell JD, Murphy B. How Does Mental Health Impact Women's Heart Health? Heart Lung Circ 2021;30:59-68. [PMID: 32665170 DOI: 10.1016/j.hlc.2020.05.111] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Park MJ, Kim H, Kim EJ, Yook V, Chung IW, Lee SM, Jeon HJ. Recent Updates on Electro-Convulsive Therapy in Patients with Depression. Psychiatry Investig 2021;18:1-10. [PMID: 33321557 DOI: 10.30773/pi.2020.0350] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Qureshi MM, Young AH. Hamlet's augury: how to manage discontinuation of mood stabilizers in bipolar disorder. Ther Adv Psychopharmacol 2021;11:20451253211000612. [PMID: 33796268 DOI: 10.1177/20451253211000612] [Reference Citation Analysis]
28 Tay K, Subramaniam P, Oei TP. Cognitive behavioural therapy can be effective in treating anxiety and depression in persons with dementia: a systematic review. Psychogeriatrics 2019;19:264-75. [DOI: 10.1111/psyg.12391] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
29 Davidson SK, Romaniuk H, Chondros P, Dowrick C, Pirkis J, Herrman H, Fletcher S, Gunn J. Antidepressant treatment for primary care patients with depressive symptoms: Data from the diamond longitudinal cohort study. Aust N Z J Psychiatry 2020;54:367-81. [DOI: 10.1177/0004867419898761] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Imaz ML, Torra M, Soy D, García-Esteve L, Martin-Santos R. Clinical Lactation Studies of Lithium: A Systematic Review. Front Pharmacol 2019;10:1005. [PMID: 31551795 DOI: 10.3389/fphar.2019.01005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
31 Lucassen MF, Stasiak K, Samra R, Frampton CM, Merry SN. Sexual minority youth and depressive symptoms or depressive disorder: A systematic review and meta-analysis of population-based studies. Aust N Z J Psychiatry 2017;51:774-87. [DOI: 10.1177/0004867417713664] [Cited by in Crossref: 60] [Cited by in F6Publishing: 38] [Article Influence: 12.0] [Reference Citation Analysis]
32 Perera C, Patterson S, Bruxner G. 'Conceivably Neglected' - Are prescribers sufficiently aware of the risks of prescribing sodium valproate to women with mental illness? Australas Psychiatry 2019;27:125-8. [PMID: 30763123 DOI: 10.1177/1039856219828175] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Tibrewal P, Bastiampillai T, Kannampuzha C, Hancox J, Dhillon R. Aripiprazole-induced neuroleptic malignant syndrome. Asian Journal of Psychiatry 2017;27:5-6. [DOI: 10.1016/j.ajp.2017.02.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
34 Hopwood MJ, Malhi G. To screen for depression or not? Med J Aust 2016;204:329. [PMID: 27169956 DOI: 10.5694/mja16.00217] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
35 Tseng MM, Chang CH, Liao SC, Chen HC. Comparison of associated features and drug treatment between co-occurring unipolar and bipolar disorders in depressed eating disorder patients. BMC Psychiatry 2017;17:81. [PMID: 28241886 DOI: 10.1186/s12888-017-1243-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
36 Rybak YE, Lai KSP, Ramasubbu R, Vila-Rodriguez F, Blumberger DM, Chan P, Delva N, Giacobbe P, Gosselin C, Kennedy SH, Iskandar H, McInerney S, Ravitz P, Sharma V, Zaretsky A, Burhan AM. Treatment-resistant major depressive disorder: Canadian expert consensus on definition and assessment. Depress Anxiety 2021;38:456-67. [PMID: 33528865 DOI: 10.1002/da.23135] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Martin DM, McClintock SM, Loo CK. Brief cognitive screening instruments for electroconvulsive therapy: Which one should I use? Aust N Z J Psychiatry 2020;54:867-73. [PMID: 32436734 DOI: 10.1177/0004867420924093] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Forsdike K, Pirotta M. St John's wort for depression: scoping review about perceptions and use by general practitioners in clinical practice. J Pharm Pharmacol 2019;71:117-28. [PMID: 28653745 DOI: 10.1111/jphp.12775] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
39 Bryce S, Cooke M, Yuen HP, Allott K. Acceptability, safety and perceived impact of providing a fact sheet to young people about cognitive symptoms in depression. Early Interv Psychiatry 2021;15:328-34. [PMID: 32043813 DOI: 10.1111/eip.12945] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Howard R, Kuhn L, Millar F, Street M. Physical health assessment and cardiometabolic monitoring practices across three adult mental health inpatient units - a retrospective cohort study. Int J Ment Health Nurs 2020;29:1144-56. [PMID: 32743951 DOI: 10.1111/inm.12755] [Reference Citation Analysis]
41 Banfield M, Farrer LM, Harrison C. Management or missed opportunity? Mental health care planning in Australian general practice. Aust J Prim Health 2019;25:332-8. [PMID: 31434606 DOI: 10.1071/PY18150] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
42 Kallestad H, Wullum E, Scott J, Stiles TC, Morken G. The long-term outcomes of an effectiveness trial of group versus individual psychoeducation for bipolar disorders. Journal of Affective Disorders 2016;202:32-8. [DOI: 10.1016/j.jad.2016.05.043] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
43 Han C, Wang G, Chan S, Kato T, Ng CH, Tan W, Zhang L, Feng Y, Liu CY. Definition and Identification of Patients with Treatment-Resistant Depression in Real-World Clinical Practice Settings Across Asia. Neuropsychiatr Dis Treat 2020;16:2929-41. [PMID: 33311981 DOI: 10.2147/NDT.S264799] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Bastiampillai T, Allison S, Gupta A, Chan SKW. Lithium, suicide prevention and unipolar depression? Aust N Z J Psychiatry 2017;51:844. [PMID: 27920059 DOI: 10.1177/0004867416682836] [Reference Citation Analysis]
45 Brinsley J, Schuch F, Lederman O, Girard D, Smout M, Immink MA, Stubbs B, Firth J, Davison K, Rosenbaum S. Effects of yoga on depressive symptoms in people with mental disorders: a systematic review and meta-analysis. Br J Sports Med 2021;55:992-1000. [PMID: 32423912 DOI: 10.1136/bjsports-2019-101242] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
46 Fountoulakis KN, Yatham L, Grunze H, Vieta E, Young A, Blier P, Kasper S, Moeller HJ. The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm. Int J Neuropsychopharmacol 2017;20:121-79. [PMID: 27816941 DOI: 10.1093/ijnp/pyw100] [Cited by in Crossref: 15] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
47 Wang HR, Bahk WM, Seo JS, Woo YS, Park YM, Jeong JH, Kim W, Shim SH, Lee JG, Jon DI, Min KJ. Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines. Clin Psychopharmacol Neurosci 2017;15:199-209. [PMID: 28783928 DOI: 10.9758/cpn.2017.15.3.199] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
48 Bennett K, Courtney D, Duda S, Henderson J, Szatmari P. An appraisal of the trustworthiness of practice guidelines for depression and anxiety in children and youth. Depress Anxiety 2018;35:530-40. [PMID: 29697887 DOI: 10.1002/da.22752] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
49 Liu B, Zhang Y, Fang H, Liu J, Liu T, Li L. Efficacy and safety of long-term antidepressant treatment for bipolar disorders – A meta-analysis of randomized controlled trials. Journal of Affective Disorders 2017;223:41-8. [DOI: 10.1016/j.jad.2017.07.023] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
50 Michalak EE, Suto MJ, Barnes SJ, Hou S, Lapsley S, Scott MW, Murray G, Austin J, Elliott NB, Berk L, Crest.bd. Effective self-management strategies for bipolar disorder: A community-engaged Delphi Consensus Consultation study. Journal of Affective Disorders 2016;206:77-86. [DOI: 10.1016/j.jad.2016.06.057] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
51 O'Donovan C, Alda M. Depression Preceding Diagnosis of Bipolar Disorder. Front Psychiatry 2020;11:500. [PMID: 32595530 DOI: 10.3389/fpsyt.2020.00500] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
52 Malhi GS, Outhred T. Opportunities for translational research in the epigenetics of mood disorders: a comment to the review by Robert M. Post. Bipolar Disord 2016;18:460-1. [PMID: 27530207 DOI: 10.1111/bdi.12421] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
53 Malhi GS, Lingford-Hughes AR, Young AH. Antidepressant treatment response: 'I want it all, and I want it now!'†. Br J Psychiatry 2016;208:101-3. [PMID: 26834163 DOI: 10.1192/bjp.bp.115.176479] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
54 Chamberlain SR, Baldwin DS. Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use them Safely and Effectively. CNS Drugs 2021;35:703-16. [PMID: 34240393 DOI: 10.1007/s40263-021-00832-x] [Reference Citation Analysis]
55 Ashton MM, Dean OM, Walker AJ, Bortolasci CC, Ng CH, Hopwood M, Harvey BH, Möller M, McGrath JJ, Marx W, Turner A, Dodd S, Scott JG, Khoo JP, Walder K, Sarris J, Berk M. The Therapeutic Potential of Mangosteen Pericarp as an Adjunctive Therapy for Bipolar Disorder and Schizophrenia. Front Psychiatry 2019;10:115. [PMID: 30918489 DOI: 10.3389/fpsyt.2019.00115] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
56 Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, Sharma V, Goldstein BI, Rej S, Beaulieu S, Alda M, MacQueen G, Milev RV, Ravindran A, O'Donovan C, McIntosh D, Lam RW, Vazquez G, Kapczinski F, McIntyre RS, Kozicky J, Kanba S, Lafer B, Suppes T, Calabrese JR, Vieta E, Malhi G, Post RM, Berk M. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord 2018;20:97-170. [PMID: 29536616 DOI: 10.1111/bdi.12609] [Cited by in Crossref: 466] [Cited by in F6Publishing: 368] [Article Influence: 116.5] [Reference Citation Analysis]
57 Mulder R, Murray G, Rucklidge J. Common versus specific factors in psychotherapy: opening the black box. Lancet Psychiatry 2017;4:953-62. [PMID: 28689019 DOI: 10.1016/S2215-0366(17)30100-1] [Cited by in Crossref: 54] [Cited by in F6Publishing: 22] [Article Influence: 10.8] [Reference Citation Analysis]
58 Døssing E, Pagsberg AK. Electroconvulsive Therapy in Children and Adolescents: A Systematic Review of Current Literature and Guidelines. J ECT 2021;37:158-70. [PMID: 34424874 DOI: 10.1097/YCT.0000000000000761] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 de Leon J, Spina E. Possible Pharmacodynamic and Pharmacokinetic Drug-Drug Interactions That Are Likely to Be Clinically Relevant and/or Frequent in Bipolar Disorder. Curr Psychiatry Rep 2018;20:17. [PMID: 29527636 DOI: 10.1007/s11920-018-0881-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
60 Byrne JEM, Tremain H, Leitan ND, Keating C, Johnson SL, Murray G. Circadian modulation of human reward function: Is there an evidentiary signal in existing neuroimaging studies? Neurosci Biobehav Rev 2019;99:251-74. [PMID: 30721729 DOI: 10.1016/j.neubiorev.2019.01.025] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
61 Dondé C, Amad A, Nieto I, Brunoni AR, Neufeld NH, Bellivier F, Poulet E, Geoffroy PA. Transcranial direct-current stimulation (tDCS) for bipolar depression: A systematic review and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 2017;78:123-31. [PMID: 28552295 DOI: 10.1016/j.pnpbp.2017.05.021] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 6.4] [Reference Citation Analysis]
62 Malhi GS, Morris G, Hamilton A, Das P, Outhred T. The ideal mood stabiliser: A quest for nirvana? Aust N Z J Psychiatry 2017;51:434-5. [DOI: 10.1177/0004867417705731] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Baird-gunning J, Lea-henry T, Hoegberg LCG, Gosselin S, Roberts DM. Lithium Poisoning. J Intensive Care Med 2017;32:249-63. [DOI: 10.1177/0885066616651582] [Cited by in Crossref: 53] [Cited by in F6Publishing: 36] [Article Influence: 8.8] [Reference Citation Analysis]
64 Firth J, Solmi M, Wootton RE, Vancampfort D, Schuch FB, Hoare E, Gilbody S, Torous J, Teasdale SB, Jackson SE, Smith L, Eaton M, Jacka FN, Veronese N, Marx W, Ashdown-Franks G, Siskind D, Sarris J, Rosenbaum S, Carvalho AF, Stubbs B. A meta-review of "lifestyle psychiatry": the role of exercise, smoking, diet and sleep in the prevention and treatment of mental disorders. World Psychiatry 2020;19:360-80. [PMID: 32931092 DOI: 10.1002/wps.20773] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 28.0] [Reference Citation Analysis]
65 Samalin L, Genty J, Boyer L, Lopez-castroman J, Abbar M, Llorca P. Shared Decision-Making: a Systematic Review Focusing on Mood Disorders. Curr Psychiatry Rep 2018;20. [DOI: 10.1007/s11920-018-0892-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
66 Clunne SJ, Ryan BJ, Hill AJ, Brandenburg C, Kneebone I. Accessibility and Applicability of Currently Available e-Mental Health Programs for Depression for People With Poststroke Aphasia: Scoping Review. J Med Internet Res 2018;20:e291. [PMID: 30514696 DOI: 10.2196/jmir.9864] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
67 Munkholm K, Jørgensen KJ, Paludan-müller AS; Cochrane Common Mental Disorders Group, Cochrane Schizophrenia Group. Adverse effects of electroconvulsive therapy. Cochrane Database of Systematic Reviews 2021;2021. [DOI: 10.1002/14651858.cd014995] [Reference Citation Analysis]
68 Fornaro M, Stubbs B, De Berardis D, Iasevoli F, Solmi M, Veronese N, Carano A, Perna G, De Bartolomeis A. Does the "Silver Bullet" Lose its Shine Over the Time? Assessment of Loss of Lithium Response in a Preliminary Sample of Bipolar Disorder Outpatients. Clin Pract Epidemiol Ment Health 2016;12:142-57. [PMID: 28217142 DOI: 10.2174/1745017901612010142] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
69 Sackeim HA, Aaronson ST, Bunker MT, Conway CR, Demitrack MA, George MS, Prudic J, Thase ME, Rush AJ. The assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form (ATHF-SF). Journal of Psychiatric Research 2019;113:125-36. [DOI: 10.1016/j.jpsychires.2019.03.021] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
70 Wells H, Crowe M, Inder M. Why people choose to participate in psychotherapy for depression: A qualitative study. J Psychiatr Ment Health Nurs 2020;27:417-24. [PMID: 31957177 DOI: 10.1111/jpm.12597] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
71 Boyce P, Hopwood M, Morris G, Hamilton A, Bassett D, Baune BT, Mulder R, Porter R, Parker G, Singh AB, Outhred T, Das P, Malhi GS. Switching antidepressants in the treatment of major depression: When, how and what to switch to? Journal of Affective Disorders 2020;261:160-3. [DOI: 10.1016/j.jad.2019.09.082] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
72 Kessler RC. The potential of predictive analytics to provide clinical decision support in depression treatment planning. Curr Opin Psychiatry 2018;31:32-9. [PMID: 29076894 DOI: 10.1097/YCO.0000000000000377] [Cited by in Crossref: 41] [Cited by in F6Publishing: 20] [Article Influence: 10.3] [Reference Citation Analysis]
73 Crowe M, Inder M, Swartz HA, Murray G, Porter R. Social rhythm therapy-A potentially translatable psychosocial intervention for bipolar disorder. Bipolar Disord 2020;22:121-7. [PMID: 31539451 DOI: 10.1111/bdi.12840] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
74 Morgan JA, Olagunju AT, Corrigan F, Baune BT. Does ceasing exercise induce depressive symptoms? A systematic review of experimental trials including immunological and neurogenic markers. J Affect Disord 2018;234:180-92. [PMID: 29529552 DOI: 10.1016/j.jad.2018.02.058] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
75 Parker GB, Graham RK, Tavella G. Is there consensus across international evidence-based guidelines for the management of bipolar disorder? Acta Psychiatr Scand 2017;135:515-26. [PMID: 28260229 DOI: 10.1111/acps.12717] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 5.6] [Reference Citation Analysis]
76 Juul S, Siddiqui F, Barbateskovic M, Jørgensen CK, Hengartner MP, Kirsch I, Gluud C, Jakobsen JC. Beneficial and harmful effects of antidepressants versus placebo, 'active placebo', or no intervention for adults with major depressive disorder: a protocol for a systematic review of published and unpublished data with meta-analyses and trial sequential analyses. Syst Rev 2021;10:154. [PMID: 34034811 DOI: 10.1186/s13643-021-01705-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
77 Henderson S. Clinical Guidelines, psychosis and other gripping things. Aust N Z J Psychiatry 2016;50:395-6. [PMID: 27106680 DOI: 10.1177/0004867416644056] [Reference Citation Analysis]
78 Howes OD, Thase ME, Pillinger T. Treatment resistance in psychiatry: state of the art and new directions. Mol Psychiatry 2021. [PMID: 34257409 DOI: 10.1038/s41380-021-01200-3] [Reference Citation Analysis]
79 Dean OM, Kanchanatawan B, Ashton M, Mohebbi M, Ng CH, Maes M, Berk L, Sughondhabirom A, Tangwongchai S, Singh AB, McKenzie H, Smith DJ, Malhi GS, Dowling N, Berk M. Adjunctive minocycline treatment for major depressive disorder: A proof of concept trial. Aust N Z J Psychiatry 2017;51:829-40. [PMID: 28578592 DOI: 10.1177/0004867417709357] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 9.8] [Reference Citation Analysis]
80 Malhi GS, Gessler D, Outhred T. The use of lithium for the treatment of bipolar disorder: Recommendations from clinical practice guidelines. J Affect Disord 2017;217:266-80. [PMID: 28437764 DOI: 10.1016/j.jad.2017.03.052] [Cited by in Crossref: 65] [Cited by in F6Publishing: 46] [Article Influence: 13.0] [Reference Citation Analysis]
81 Öhlund L, Ott M, Bergqvist M, Oja S, Lundqvist R, Sandlund M, Renberg ES, Werneke U. Clinical course and need for hospital admission after lithium discontinuation in patients with bipolar disorder type I or II: mirror-image study based on the LiSIE retrospective cohort. BJPsych Open 2019;5:e101. [PMID: 31753046 DOI: 10.1192/bjo.2019.83] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
82 Smith L, Johns L, Mitchell R. Characterizing the experience of auditory verbal hallucinations and accompanying delusions in individuals with a diagnosis of bipolar disorder: A systematic review. Bipolar Disord 2017;19:417-33. [DOI: 10.1111/bdi.12520] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 4.4] [Reference Citation Analysis]
83 Brouillette J, Nattel S. A Practical Approach to Avoiding Cardiovascular Adverse Effects of Psychoactive Medications. Canadian Journal of Cardiology 2017;33:1577-86. [DOI: 10.1016/j.cjca.2017.09.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 2.4] [Reference Citation Analysis]
84 Opie RS, Jacka FN, Marx W, Rocks T, Young C, O'Neil A. Designing Lifestyle Interventions for Common Mental Disorders: What Can We Learn from Diabetes Prevention Programs? Nutrients 2021;13:3766. [PMID: 34836024 DOI: 10.3390/nu13113766] [Reference Citation Analysis]
85 Baxter D, Lovell GP. Australian mental health practitioners’ reported practice, beliefs, and barriers to the prescription of dietary change for mental health conditions. Australian Psychologist 2021;56:245-55. [DOI: 10.1080/00050067.2021.1893597] [Reference Citation Analysis]
86 Kim HY, Lee HJ, Jhon M, Kim JW, Kang HJ, Lee JY, Kim SW, Shin IS, Kim JM. Predictors of Remission in Acute and Continuation Treatment of Depressive Disorders. Clin Psychopharmacol Neurosci 2021;19:490-7. [PMID: 34294617 DOI: 10.9758/cpn.2021.19.3.490] [Reference Citation Analysis]
87 Malhi GS, Outhred T, Morris G, Boyce PM, Bryant R, Fitzgerald PB, Hopwood MJ, Lyndon B, Mulder R, Murray G, Porter RJ, Singh AB, Fritz K. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders: bipolar disorder summary. Medical Journal of Australia 2018;208:219-25. [DOI: 10.5694/mja17.00658] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 6.5] [Reference Citation Analysis]
88 Du L, Chen YM, Jin X, Yuan W, Wang JS. Critical appraisal of clinical practice guidelines for depression in children and adolescents: A protocol for systematic review. Medicine (Baltimore) 2020;99:e22384. [PMID: 32957419 DOI: 10.1097/MD.0000000000022384] [Reference Citation Analysis]
89 Hobbs MJ, Joubert AE, Mahoney AEJ, Andrews G. Treating late-life depression: Comparing the effects of internet-delivered cognitive behavior therapy across the adult lifespan. J Affect Disord 2018;226:58-65. [PMID: 28963865 DOI: 10.1016/j.jad.2017.09.026] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 4.2] [Reference Citation Analysis]
90 Taylor RW, Marwood L, Oprea E, DeAngel V, Mather S, Valentini B, Zahn R, Young AH, Cleare AJ. Pharmacological Augmentation in Unipolar Depression: A Guide to the Guidelines. Int J Neuropsychopharmacol 2020;23:587-625. [PMID: 32402075 DOI: 10.1093/ijnp/pyaa033] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
91 Marashdeh RAM, Parsons R, Sim TF. Antidepressant Prescribing Patterns in Heart Failure Patients at Residential Aged Care Facilities in Australia: A Cross-sectional Study. J Res Pharm Pract 2019;8:69-74. [PMID: 31367641 DOI: 10.4103/jrpp.JRPP_18_63] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
92 Gallur L, Powell A, Flynn P. Recommencing lithium in Older Adults with Bipolar I Disorder. Australas Psychiatry 2017;25:571-3. [PMID: 29087206 DOI: 10.1177/1039856217738374] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
93 Boyce P, Irwin L, Morris G, Hamilton A, Mulder R, Malhi GS, Porter RJ. Long-acting injectable antipsychotics as maintenance treatments for bipolar disorder-A critical review of the evidence. Bipolar Disord 2018;20 Suppl 2:25-36. [PMID: 30328222 DOI: 10.1111/bdi.12698] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
94 Kan C, Hawkings YR, Cribben H, Treasure J. Length of stay for anorexia nervosa: Systematic review and meta-analysis. Eur Eat Disord Rev 2021;29:371-92. [PMID: 33548148 DOI: 10.1002/erv.2820] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
95 Bullock B, Murray G, Meyer D. Highs and lows, ups and downs: Meteorology and mood in bipolar disorder. PLoS One 2017;12:e0173431. [PMID: 28278268 DOI: 10.1371/journal.pone.0173431] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
96 Bessonova L, Ogden K, Doane MJ, O'Sullivan AK, Tohen M. The Economic Burden of Bipolar Disorder in the United States: A Systematic Literature Review. Clinicoecon Outcomes Res 2020;12:481-97. [PMID: 32982338 DOI: 10.2147/CEOR.S259338] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
97 Brett J, Pearson SA, Daniels B, Wylie CE, Buckley NA. A cross sectional study of psychotropic medicine use in Australia in 2018: A focus on polypharmacy. Br J Clin Pharmacol 2021;87:1369-77. [PMID: 32881057 DOI: 10.1111/bcp.14527] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
98 Bradley HA, Campbell SA, Mulder RT, Henderson JMT, Dixon L, Boden JM, Rucklidge JJ. Can broad-spectrum multinutrients treat symptoms of antenatal depression and anxiety and improve infant development? Study protocol of a double blind, randomized, controlled trial (the 'NUTRIMUM' trial). BMC Pregnancy Childbirth 2020;20:488. [PMID: 32842983 DOI: 10.1186/s12884-020-03143-z] [Reference Citation Analysis]
99 Ekkekakis P, Murri MB. Exercise as antidepressant treatment: Time for the transition from trials to clinic? Gen Hosp Psychiatry 2017;49:1. [PMID: 29122144 DOI: 10.1016/j.genhosppsych.2017.04.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
100 Ashton MM, Berk M, Ng CH, Hopwood M, Dodd S, Turner A, Brown E, Jacka FN, Cotton SM, Khoo JP, Chatterton ML, Kavanagh BE, Nadjidai SE, Lo Monaco SL, Harvey BH, Sarris J, Malhi GS, Dowling NL, Dean OM. Efficacy of adjunctive Garcinia mangostana Linn (mangosteen) pericarp for bipolar depression: study protocol for a proof-of-concept trial. Braz J Psychiatry 2019;41:245-53. [PMID: 30328970 DOI: 10.1590/1516-4446-2018-0114] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
101 Crowe M, Eggleston K, Douglas K, Porter RJ. Effects of psychotherapy on comorbid bipolar disorder and substance use disorder: A systematic review. Bipolar Disord 2021;23:141-51. [PMID: 32615028 DOI: 10.1111/bdi.12971] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
102 Schuch FB, Schoenell MCW, Tiggemann CL, Noll M, Alberton CL, Kruel LFM. The effects of water-based strength exercise on quality of life in young women. Sport Sci Health 2016;12:105-12. [DOI: 10.1007/s11332-016-0261-5] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
103 Dardas LA. Family functioning moderates the impact of depression treatment on adolescents’ suicidal ideations. Child Adolesc Ment Health 2019;24:251-8. [DOI: 10.1111/camh.12323] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
104 Samalin L, Yrondi A, Charpeaud T, Genty JB, Blanc O, Sauvaget A, Stéphan F, Walter M, Bennabi D, Bulteau S, Haesebaert F, D'Amato T, Poulet E, Holtzmann J, Richieri RM, Attal J, Nieto I, El-Hage W, Bellivier F, Schmitt L, Lançon C, Bougerol T, Leboyer M, Aouizerate B, Haffen E, Courtet P, Llorca PM. Adherence to treatment guidelines in clinical practice for using electroconvulsive therapy in major depressive episode. J Affect Disord 2020;264:318-23. [PMID: 32056767 DOI: 10.1016/j.jad.2020.01.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
105 Jauhar S, Young AH. Controversies in bipolar disorder; role of second-generation antipsychotic for maintenance therapy. Int J Bipolar Disord 2019;7:10. [PMID: 30915592 DOI: 10.1186/s40345-019-0145-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
106 Rodenburg-Vandenbussche S, Carlier IVE, van Vliet IM, van Hemert AM, Stiggelbout AM, Zitman FG. Clinical and sociodemographic associations with treatment selection in major depression. Gen Hosp Psychiatry 2018;54:18-24. [PMID: 30048764 DOI: 10.1016/j.genhosppsych.2018.06.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
107 Romijn AR, Rucklidge JJ, Kuijer RG, Frampton C. A double-blind, randomized, placebo-controlled trial of Lactobacillus helveticus and Bifidobacterium longum for the symptoms of depression. Aust N Z J Psychiatry 2017;51:810-21. [PMID: 28068788 DOI: 10.1177/0004867416686694] [Cited by in Crossref: 103] [Cited by in F6Publishing: 92] [Article Influence: 20.6] [Reference Citation Analysis]
108 Everitt N, Broadbent J, Richardson B, Smyth JM, Heron K, Teague S, Fuller-Tyszkiewicz M. Exploring the features of an app-based just-in-time intervention for depression. J Affect Disord 2021;291:279-87. [PMID: 34058610 DOI: 10.1016/j.jad.2021.05.021] [Reference Citation Analysis]
109 Fang G, Wang Y. Effects of rTMS on Hippocampal Endocannabinoids and Depressive-like Behaviors in Adolescent Rats. Neurochem Res. 2018;43:1756-1765. [PMID: 29987693 DOI: 10.1007/s11064-018-2591-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
110 Chia MF, Cotton S, Filia K, Phelan M, Conus P, Jauhar S, Marwaha S, Mcgorry PD, Davey C, Berk M, Ratheesh A. Early intervention for bipolar disorder – Do current treatment guidelines provide recommendations for the early stages of the disorder? Journal of Affective Disorders 2019;257:669-77. [DOI: 10.1016/j.jad.2019.07.062] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
111 Fritz K, Russell AMT, Allwang C, Kuiper S, Lampe L, Malhi GS. Is a delay in the diagnosis of bipolar disorder inevitable? Bipolar Disord 2017;19:396-400. [DOI: 10.1111/bdi.12499] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 8.4] [Reference Citation Analysis]
112 Molenaar NM, Poels EMP, Robakis T, Wesseloo R, Bergink V. Management of lithium dosing around delivery: An observational study. Bipolar Disord 2021;23:49-54. [PMID: 32526071 DOI: 10.1111/bdi.12955] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
113 Hatcher S. Good guidelines but should the emphasis be on implementation? Aust N Z J Psychiatry 2017;51:15-7. [PMID: 28030976 DOI: 10.1177/0004867416681857] [Reference Citation Analysis]
114 Zhou X, Guo J, Lu G, Chen C, Xie Z, Liu J, Zhang C. Effects of mindfulness-based stress reduction on anxiety symptoms in young people: A systematic review and meta-analysis. Psychiatry Research 2020;289:113002. [DOI: 10.1016/j.psychres.2020.113002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
115 Andrews G, Bell C, Boyce P, Gale C, Lampe L, Marwat O, Rapee R, Wilkins G. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of panic disorder, social anxiety disorder and generalised anxiety disorder. Aust N Z J Psychiatry 2018;52:1109-72. [DOI: 10.1177/0004867418799453] [Cited by in Crossref: 57] [Cited by in F6Publishing: 27] [Article Influence: 14.3] [Reference Citation Analysis]
116 Jørgensen CK, Juul S, Siddiqui F, Barbateskovic M, Munkholm K, Hengartner MP, Kirsch I, Gluud C, Jakobsen JC. Tricyclic antidepressants versus 'active placebo', placebo or no intervention for adults with major depressive disorder: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis. Syst Rev 2021;10:227. [PMID: 34389045 DOI: 10.1186/s13643-021-01789-0] [Reference Citation Analysis]
117 Jakobsen JC, Gluud C, Kirsch I. Should antidepressants be used for major depressive disorder? BMJ Evid Based Med 2020;25:130. [PMID: 31554608 DOI: 10.1136/bmjebm-2019-111238] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
118 Wrobel A, Russell SE, Dean OM, Cotton S, Berk M, Turner A. Influence of childhood trauma on the treatment outcomes of pharmacological and/or psychological interventions for adolescents and adults with bipolar disorder: protocol for a systematic review and meta-analysis. BMJ Open 2021;11:e044569. [PMID: 33926981 DOI: 10.1136/bmjopen-2020-044569] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
119 Sharma V, Sharma S. Peripartum management of bipolar disorder: what do the latest guidelines recommend? Expert Rev Neurother 2017;17:335-44. [PMID: 27769136 DOI: 10.1080/14737175.2017.1243470] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
120 Schuch FB, Morres ID, Ekkekakis P, Rosenbaum S, Stubbs B. A critical review of exercise as a treatment for clinically depressed adults: time to get pragmatic. Acta Neuropsychiatr 2017;29:65-71. [PMID: 27145824 DOI: 10.1017/neu.2016.21] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 5.3] [Reference Citation Analysis]
121 Adams J, McIntyre E, Frawley J, Lauche R, Broom A, Sibbritt D. Formal and informal healthcare behaviours of women with chronic illness: A cross-sectional analysis of 1925 women. Int J Clin Pract 2019;73:e13343. [PMID: 30859664 DOI: 10.1111/ijcp.13343] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
122 Graham RK, Tavella G, Parker GB. Is there consensus across international evidence-based guidelines for the psychotropic drug management of bipolar disorder during the perinatal period? J Affect Disord 2018;228:216-21. [PMID: 29274567 DOI: 10.1016/j.jad.2017.12.022] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
123 Moeller SB, Gbyl K, Hjorthøj C, Andreasen M, Austin SF, Buchholtz PE, Fønss L, Hjerrild S, Hogervorst L, Jørgensen MB, Ladegaard N, Martiny K, Meile J, Packness A, Sigaard KR, Straarup K, Straszek SPV, Soerensen CH, Welcher B, Videbech P. Treatment of difficult-to-treat depression - clinical guideline for selected interventions. Nord J Psychiatry 2021;:1-12. [PMID: 34455900 DOI: 10.1080/08039488.2021.1952303] [Reference Citation Analysis]
124 Weiss A, Hussain S, Ng B, Sarma S, Tiller J, Waite S, Loo C. Royal Australian and New Zealand College of Psychiatrists professional practice guidelines for the administration of electroconvulsive therapy. Aust N Z J Psychiatry 2019;53:609-23. [DOI: 10.1177/0004867419839139] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 11.3] [Reference Citation Analysis]
125 Moot W, Crowe M, Inder M, Eggleston K, Frampton C, Porter R. Functional and Mood Outcomes in Bipolar Disorder Patients With and Without Substance Use Disorders Undergoing Psychotherapy. Front Psychiatry 2021;12:661458. [PMID: 34594244 DOI: 10.3389/fpsyt.2021.661458] [Reference Citation Analysis]
126 Malhi GS, Morris G, Hamilton A, Outhred T, Mannie Z. Is “early intervention” in bipolar disorder what it claims to be? Bipolar Disord 2017;19:627-36. [DOI: 10.1111/bdi.12576] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
127 Way K, Kannis-dymand L, Lastella M, Lovell GP. Mental health practitioners’ reported barriers to prescription of exercise for mental health consumers. Mental Health and Physical Activity 2018;14:52-60. [DOI: 10.1016/j.mhpa.2018.01.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 5.3] [Reference Citation Analysis]
128 Mulder R, Singh AB, Hamilton A, Das P, Outhred T, Morris G, Bassett D, Baune BT, Berk M, Boyce P, Lyndon B, Parker G, Malhi GS. The limitations of using randomised controlled trials as a basis for developing treatment guidelines. Evid Based Ment Health 2018;21:4-6. [PMID: 28710065 DOI: 10.1136/eb-2017-102701] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 6.8] [Reference Citation Analysis]
129 Cheniaux E, Nardi AE. Evaluating the efficacy and safety of antidepressants in patients with bipolar disorder. Expert Opinion on Drug Safety 2019;18:893-913. [DOI: 10.1080/14740338.2019.1651291] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
130 Vicenzino B, Britt H, Pollack AJ, Hall M, Bennell KL, Hunter DJ. No abatement of steroid injections for tennis elbow in Australian General Practice: A 15-year observational study with random general practitioner sampling. PLoS One 2017;12:e0181631. [PMID: 28727755 DOI: 10.1371/journal.pone.0181631] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
131 Bai G, Qiao Y, Lo PC, Song L, Yang Y, Duan L, Wei S, Li M, Huang S, Zhang B, Wang Q, Yang C. Anti-depressive effects of Jiao-Tai-Wan on CORT-induced depression in mice by inhibiting inflammation and microglia activation. J Ethnopharmacol 2022;283:114717. [PMID: 34627986 DOI: 10.1016/j.jep.2021.114717] [Reference Citation Analysis]
132 Juruena MF, Jelen LA, Young AH, Cleare AJ. New Pharmacological Interventions in Bipolar Disorder. Curr Top Behav Neurosci 2021;48:303-24. [PMID: 33547595 DOI: 10.1007/7854_2020_181] [Reference Citation Analysis]
133 Jauhar S, Ratheesh A, Davey C, Yatham LN, Mcgorry PD, Mcguire P, Berk M, Young AH. The case for improved care and provision of treatment for people with first-episode mania. The Lancet Psychiatry 2019;6:869-76. [DOI: 10.1016/s2215-0366(19)30082-3] [Cited by in Crossref: 18] [Article Influence: 6.0] [Reference Citation Analysis]
134 Jalenques I, Rachez C, Jalenques UT, Nechifor SA, Morel L, Blanchard F, Pereira B, Lauron S, Rondepierre F; French DAS/PDAS group. Cross-cultural evaluation of the French version of the Delusion Assessment Scale (DAS) and Psychotic Depression Assessment Scale (PDAS). PLoS One 2021;16:e0250492. [PMID: 33901242 DOI: 10.1371/journal.pone.0250492] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
135 Dipnall JF, Pasco JA, Berk M, Williams LJ, Dodd S, Jacka FN, Meyer D. Getting RID of the blues: Formulating a Risk Index for Depression (RID) using structural equation modeling. Aust N Z J Psychiatry 2017;51:1121-33. [DOI: 10.1177/0004867417726860] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
136 Saha S, Lim CC, Degenhardt L, Cannon DL, Bremner M, Prentis F, Lawrence Z, Heffernan E, Meurk C, Reilly J, McGrath JJ. Comorbidity between mood and substance-related disorders: A systematic review and meta-analysis. Aust N Z J Psychiatry 2021;:48674211054740. [PMID: 34708662 DOI: 10.1177/00048674211054740] [Reference Citation Analysis]
137 Malhi GS, Byrow Y, Cassidy F, Cipriani A, Demyttenaere K, Frye MA, Gitlin M, Kennedy SH, Ketter TA, Lam RW, McShane R, Mitchell AJ, Ostacher MJ, Rizvi SJ, Thase ME, Tohen M. Ketamine: stimulating antidepressant treatment? BJPsych Open 2016;2:e5-9. [PMID: 27703782 DOI: 10.1192/bjpo.bp.116.002923] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
138 Dodd S, Bauer M, Carvalho AF, Eyre H, Fava M, Kasper S, Kennedy SH, Khoo J, Lopez Jaramillo C, Malhi GS, Mcintyre RS, Mitchell PB, Castro AMP, Ratheesh A, Severus E, Suppes T, Trivedi MH, Thase ME, Yatham LN, Young AH, Berk M. A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don’t work well enough? The World Journal of Biological Psychiatry 2021;22:483-94. [DOI: 10.1080/15622975.2020.1851052] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
139 Geoffroy PA, Palagini L. Biological rhythms and chronotherapeutics in depression. Prog Neuropsychopharmacol Biol Psychiatry 2021;106:110158. [PMID: 33152388 DOI: 10.1016/j.pnpbp.2020.110158] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
140 Fibbins H, Czosnek L, Stanton R, Davison K, Lederman O, Morell R, Ward P, Rosenbaum S. Self-reported physical activity levels of the 2017 Royal Australian and New Zealand College of Psychiatrists (RANZCP) conference delegates and their exercise referral practices. J Ment Health 2020;29:565-72. [PMID: 30322334 DOI: 10.1080/09638237.2018.1521935] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
141 Sakurai H, Uchida H, Kato M, Suzuki T, Baba H, Watanabe K, Inada K, Kikuchi T, Katsuki A, Kishida I, Sugawara Kikuchi Y, Yasui-furukori N. Pharmacological management of depression: Japanese expert consensus. Journal of Affective Disorders 2020;266:626-32. [DOI: 10.1016/j.jad.2020.01.149] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
142 Jawad I, Watson S, Haddad PM, Talbot PS, McAllister-Williams RH. Medication nonadherence in bipolar disorder: a narrative review. Ther Adv Psychopharmacol 2018;8:349-63. [PMID: 30524703 DOI: 10.1177/2045125318804364] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 10.8] [Reference Citation Analysis]
143 Lopresti AL. Cognitive behaviour therapy and inflammation: A systematic review of its relationship and the potential implications for the treatment of depression. Aust N Z J Psychiatry 2017;51:565-82. [DOI: 10.1177/0004867417701996] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 8.2] [Reference Citation Analysis]
144 Wrobel AL, Jayasinghe A, Russell SE, Marx W, Alameda L, Dean OM, Cotton SM, Berk M, Turner A. The influence of childhood trauma on the treatment outcomes of pharmacological and/or psychological interventions for adolescents and adults with bipolar disorder: A systematic review and meta-analysis. J Affect Disord 2022;296:350-62. [PMID: 34606813 DOI: 10.1016/j.jad.2021.09.103] [Reference Citation Analysis]
145 Bidargaddi N, Schrader G, Myles H, Schubert KO, van Kasteren Y, Zhang T, Bastiampillai T, Roughead E, Strobel J. Demonstration of automated non-adherence and service disengagement risk monitoring with active follow-up for severe mental illness. Aust N Z J Psychiatry 2021;55:976-82. [PMID: 33745291 DOI: 10.1177/0004867421998800] [Reference Citation Analysis]
146 Bayes AJ, Parker GB. Comparison of guidelines for the treatment of unipolar depression: a focus on pharmacotherapy and neurostimulation. Acta Psychiatr Scand 2018;137:459-71. [DOI: 10.1111/acps.12878] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 7.8] [Reference Citation Analysis]
147 Duncan MJ, Rayward AT, Holliday EG, Brown WJ, Vandelanotte C, Murawski B, Plotnikoff RC. Effect of a physical activity and sleep m-health intervention on a composite activity-sleep behaviour score and mental health: a mediation analysis of two randomised controlled trials. Int J Behav Nutr Phys Act 2021;18:45. [PMID: 33766051 DOI: 10.1186/s12966-021-01112-z] [Reference Citation Analysis]
148 Smith B, Dubovsky SL. Pharmacotherapy of mood disorders and psychosis in pre- and post-natal women. Expert Opinion on Pharmacotherapy 2017;18:1703-19. [DOI: 10.1080/14656566.2017.1391789] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
149 Le Clerc S, Lombardi L, Baune BT, Amare AT, Schubert KO, Hou L, Clark SR, Papiol S, Cearns M, Heilbronner U, Degenhardt F, Tekola-Ayele F, Hsu YH, Shekhtman T, Adli M, Akula N, Akiyama K, Ardau R, Arias B, Aubry JM, Backlund L, Bhattacharjee AK, Bellivier F, Benabarre A, Bengesser S, Biernacka JM, Birner A, Brichant-Petitjean C, Cervantes P, Chen HC, Chillotti C, Cichon S, Cruceanu C, Czerski PM, Dalkner N, Dayer A, Del Zompo M, DePaulo JR, Étain B, Jamain S, Falkai P, Forstner AJ, Frisen L, Frye MA, Fullerton JM, Gard S, Garnham JS, Goes FS, Grigoroiu-Serbanescu M, Grof P, Hashimoto R, Hauser J, Herms S, Hoffmann P, Jiménez E, Kahn JP, Kassem L, Kuo PH, Kato T, Kelsoe JR, Kittel-Schneider S, Ferensztajn-Rochowiak E, König B, Kusumi I, Laje G, Landén M, Lavebratt C, Leckband SG, Tortorella A, Manchia M, Martinsson L, McCarthy MJ, McElroy SL, Colom F, Millischer V, Mitjans M, Mondimore FM, Monteleone P, Nievergelt CM, Nöthen MM, Novák T, O'Donovan C, Ozaki N, Ösby U, Pfennig A, Potash JB, Reif A, Reininghaus E, Rouleau GA, Rybakowski JK, Schalling M, Schofield PR, Schweizer BW, Severino G, Shilling PD, Shimoda K, Simhandl C, Slaney CM, Pisanu C, Squassina A, Stamm T, Stopkova P, Maj M, Turecki G, Vieta E, Veeh J, Witt SH, Wright A, Zandi PP, Mitchell PB, Bauer M, Alda M, Rietschel M, McMahon FJ, Schulze TG, Spadoni JL, Boukouaci W, Richard JR, Le Corvoisier P, Barrau C, Zagury JF, Leboyer M, Tamouza R. HLA-DRB1 and HLA-DQB1 genetic diversity modulates response to lithium in bipolar affective disorders. Sci Rep 2021;11:17823. [PMID: 34497278 DOI: 10.1038/s41598-021-97140-7] [Reference Citation Analysis]
150 Fornaro M, Carvalho AF, Fusco A, Anastasia A, Solmi M, Berk M, Sim K, Vieta E, de Bartolomeis A. The concept and management of acute episodes of treatment-resistant bipolar disorder: a systematic review and exploratory meta-analysis of randomized controlled trials. J Affect Disord 2020;276:970-83. [PMID: 32750614 DOI: 10.1016/j.jad.2020.07.109] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
151 Davey CG, Chanen AM. The unfulfilled promise of the antidepressant medications. Med J Aust 2016;204:348-50. [PMID: 27169968 DOI: 10.5694/mja16.00194] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
152 Molenaar NM, Kamperman AM, Boyce P, Bergink V. Guidelines on treatment of perinatal depression with antidepressants: An international review. Aust N Z J Psychiatry 2018;52:320-7. [PMID: 29506399 DOI: 10.1177/0004867418762057] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 8.3] [Reference Citation Analysis]
153 Geoffroy PA, Schroder CM, Reynaud E, Bourgin P. Efficacy of light therapy versus antidepressant drugs, and of the combination versus monotherapy, in major depressive episodes: A systematic review and meta-analysis. Sleep Medicine Reviews 2019;48:101213. [DOI: 10.1016/j.smrv.2019.101213] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
154 Wilson L, Crowe M, Scott A, Lacey C. Psychoeducation for bipolar disorder: A discourse analysis. Int J Mental Health Nurs 2018;27:349-57. [DOI: 10.1111/inm.12328] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
155 Jackson A, Seneviratne U. EEG changes in patients on antipsychotic therapy: A systematic review. Epilepsy & Behavior 2019;95:1-9. [DOI: 10.1016/j.yebeh.2019.02.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
156 Francis-Taylor R, Ophel G, Martin D, Loo C. The ictal EEG in ECT: A systematic review of the relationships between ictal features, ECT technique, seizure threshold and outcomes. Brain Stimul 2020;13:1644-54. [PMID: 32998055 DOI: 10.1016/j.brs.2020.09.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
157 Fletcher K, Murray G. Beyond Pharmacotherapy for Bipolar Disorder: The Role of Adjunctive Psychological Treatments. Psychiatric Annals 2019;49:399-404. [DOI: 10.3928/00485713-20190808-01] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
158 Kohls E, Hug J, Stahl M, Driessen P, Roemer C, Wollschlaeger E, Moldenhauer K, Rummel-Kluge C. Peer counseling in depression care: A pilot study in a psychiatric inpatient setting. Psychiatry Res 2018;270:698-704. [PMID: 30551312 DOI: 10.1016/j.psychres.2018.10.058] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
159 Manuel J, Crowe M, Inder M, Henaghan M. Suicide prevention in mental health services: A qualitative analysis of coroners' reports. Int J Ment Health Nurs 2018;27:642-51. [PMID: 28493403 DOI: 10.1111/inm.12349] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
160 Carpenter JS, Crouse JJ, Scott EM, Naismith SL, Wilson C, Scott J, Merikangas KR, Hickie IB. Circadian depression: A mood disorder phenotype. Neurosci Biobehav Rev 2021;126:79-101. [PMID: 33689801 DOI: 10.1016/j.neubiorev.2021.02.045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
161 Fiorillo A, Carpiniello B, De Giorgi S, La Pia S, Maina G, Sampogna G, Spina E, Tortorella A, Vita A. Assessment and Management of Cognitive and Psychosocial Dysfunctions in Patients With Major Depressive Disorder: A Clinical Review. Front Psychiatry 2018;9:493. [PMID: 30364225 DOI: 10.3389/fpsyt.2018.00493] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
162 Fletcher K, Murray G. Towards tailored psychosocial intervention for BD-II: Lived experience perspectives on current and future management options. J Affect Disord 2021;289:110-6. [PMID: 33975089 DOI: 10.1016/j.jad.2021.04.018] [Reference Citation Analysis]
163 Samalin L, Murru A, Vieta E. Management of inter-episodic periods in patients with bipolar disorder. Expert Rev Neurother 2016;16:659-70. [PMID: 27058008 DOI: 10.1080/14737175.2016.1176530] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
164 Haber PS, Riordan BC, Winter DT, Barrett L, Saunders J, Hides L, Gullo M, Manning V, Day CA, Bonomo Y, Burns L, Assan R, Curry K, Mooney-Somers J, Demirkol A, Monds L, McDonough M, Baillie AJ, Clark P, Ritter A, Quinn C, Cunningham J, Lintzeris N, Rombouts S, Savic M, Norman A, Reid S, Hutchinson D, Zheng C, Iese Y, Black N, Draper B, Ridley N, Gowing L, Stapinski L, Taye B, Lancaster K, Stjepanović D, Kay-Lambkin F, Jamshidi N, Lubman D, Pastor A, White N, Wilson S, Jaworski AL, Memedovic S, Logge W, Mills K, Seear K, Freeburn B, Lea T, Withall A, Marel C, Boffa J, Roxburgh A, Purcell-Khodr G, Doyle M, Conigrave K, Teesson M, Butler K, Connor J, Morley KC. New Australian guidelines for the treatment of alcohol problems: an overview of recommendations. Med J Aust 2021;215 Suppl 7:S3-S32. [PMID: 34601742 DOI: 10.5694/mja2.51254] [Reference Citation Analysis]
165 Kim JM, Stewart R, Kang HJ, Kim JW, Lee HJ, Jhon M, Lee JY, Kim SW, Shin IS. Short and long-term treatment outcomes of stepwise psychopharmacotherapy based on early clinical decision in patients with depressive disorders. J Affect Disord 2020;274:315-25. [PMID: 32469822 DOI: 10.1016/j.jad.2020.05.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
166 Hackett ML, Teixeira‐pinto A, Farnbach S, Glozier N, Skinner T, Askew DA, Gee G, Cass A, Brown A; The Getting it Right Collaborative Group. Getting it Right: validating a culturally specific screening tool for depression ( aPHQ ‐9) in Aboriginal and Torres Strait Islander Australians. Medical Journal of Australia 2019;211:24-30. [DOI: 10.5694/mja2.50212] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
167 Arden-Close E, Mitchell F, Davies G, Bell L, Fogg C, Tarrant R, Gibbs R, Yeoh CC. Mindfulness-Based Interventions in Recurrent Ovarian Cancer: A Mixed-Methods Feasibility Study. Integr Cancer Ther 2020;19:1534735420908341. [PMID: 32174190 DOI: 10.1177/1534735420908341] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
168 Ashton MM, Kavanagh BE, Marx W, Berk M, Sarris J, Ng CH, Hopwood M, Williams LJ, Dean OM. A Systematic Review of Nutraceuticals for the Treatment of Bipolar Disorder. Can J Psychiatry 2021;66:262-73. [PMID: 32966097 DOI: 10.1177/0706743720961734] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
169 Choi W, Stewart R, Kang HJ, Kim JW, Kim HK, Kang HC, Lee JY, Kim SW, Kim JM. Interactive effects of systemic inflammation and life stressors on treatment response of depressive disorders. Brain Behav Immun 2021;95:61-7. [PMID: 33548497 DOI: 10.1016/j.bbi.2021.01.029] [Reference Citation Analysis]
170 Schaffer AL, Zoega H, Tran DT, Buckley NA, Pearson S, Havard A. Trajectories of antipsychotic use before and during pregnancy and associated maternal and birth characteristics. Aust N Z J Psychiatry 2019;53:1208-21. [DOI: 10.1177/0004867419847764] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
171 Hayward J, Jacka FN, Skouteris H, Millar L, Strugnell C, Swinburn BA, Allender S. Lifestyle factors and adolescent depressive symptomatology: Associations and effect sizes of diet, physical activity and sedentary behaviour. Aust N Z J Psychiatry 2016;50:1064-73. [DOI: 10.1177/0004867416671596] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
172 Luty SE, Scalia S. Can interpersonal psychotherapy be delivered by a community agency? Australas Psychiatry 2018;26:200-5. [PMID: 29409335 DOI: 10.1177/1039856217751784] [Reference Citation Analysis]
173 Wynter E, Perich T. Use of self‐care strategies in the management of bipolar disorder and their relationship to symptoms, illness intrusiveness, and quality of life. Clinical Psychologist 2019;23:133-43. [DOI: 10.1111/cp.12149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
174 Colomer L, Anmella G, Vieta E, Grande I. Physical health in affective disorders: a narrative review of the literature. Braz J Psychiatry. [DOI: 10.1590/1516-4446-2020-1246] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
175 Iglesias-gonzález M, Aznar-lou I, Gil-girbau M, Moreno-peral P, Peñarrubia-maría MT, Rubio-valera M, Serrano-blanco A. Comparing watchful waiting with antidepressants for the management of subclinical depression symptoms to mild–moderate depression in primary care: a systematic review. Family Practice 2017;34:639-48. [DOI: 10.1093/fampra/cmx054] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
176 Fifer S, Puig A, Sequeira V, Acar M, Ng CH, Blanchard M, Cabrera A, Freemantle J, Grunfeld J. Understanding Treatment Preferences of Australian Patients Living with Treatment-Resistant Depression. Patient Prefer Adherence 2021;15:1621-37. [PMID: 34321870 DOI: 10.2147/PPA.S311699] [Reference Citation Analysis]
177 Jacka FN, O'Neil A, Opie R, Itsiopoulos C, Cotton S, Mohebbi M, Castle D, Dash S, Mihalopoulos C, Chatterton ML, Brazionis L, Dean OM, Hodge AM, Berk M. A randomised controlled trial of dietary improvement for adults with major depression (the 'SMILES' trial). BMC Med. 2017;15:23. [PMID: 28137247 DOI: 10.1186/s12916-017-0791-y] [Cited by in Crossref: 272] [Cited by in F6Publishing: 229] [Article Influence: 54.4] [Reference Citation Analysis]
178 Ekkekakis P, Murri MB. Exercise as antidepressant treatment: Time for the transition from trials to clinic? General Hospital Psychiatry 2017;49:A1-5. [DOI: 10.1016/j.genhosppsych.2017.11.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
179 McLaren R, Cipriani A. Clinical guidelines for mood disorders: The roads travelled, the road ahead. Aust N Z J Psychiatry 2016;50:1123-4. [PMID: 27789651 DOI: 10.1177/0004867416676371] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
180 Craig A, Guest R, Tran Y, Middleton J. Depressive mood in adults with spinal cord injury as they transition from an inpatient to a community setting: secondary analyses from a clinical trial. Spinal Cord 2017;55:926-34. [PMID: 28462933 DOI: 10.1038/sc.2017.41] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
181 Jhon M, Stewart R, Kim JW, Kang HJ, Lee JY, Kim SW, Shin IS, Kim JM. Predictors and outcomes of experienced and anticipated discrimination in patients treated for depression: A 2-year longitudinal study. J Affect Disord 2021;294:761-8. [PMID: 34375201 DOI: 10.1016/j.jad.2021.07.049] [Reference Citation Analysis]
182 Weiß L, Zeeck A, Rottler E, Weiß H, Hartmann A, von Wietersheim J; INDDEP Study Group. Follow-Up Treatment After Inpatient Therapy of Patients With Unipolar Depression-Compliance With the Guidelines? Front Psychiatry 2020;11:796. [PMID: 32848954 DOI: 10.3389/fpsyt.2020.00796] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
183 Malhi GS, Fritz K, Elangovan P, Irwin L. Mixed States: Modelling and Management. CNS Drugs 2019;33:301-13. [PMID: 30712252 DOI: 10.1007/s40263-019-00609-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
184 Malhi GS, Outhred T, Hamilton A, Morris G, Mannie Z. Early intervention in bipolar disorder is not what it claims to be! Bipolar Disord 2018;20:414-6. [DOI: 10.1111/bdi.12667] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
185 Morton E, Murray G, Yatham LN, Lam RW, Michalak EE. The Quality of Life in Bipolar Disorder (QoL.BD) questionnaire a decade on - A systematic review of the measurement of condition-specific aspects of quality of life in bipolar-disorder. J Affect Disord 2021;278:33-45. [PMID: 32949871 DOI: 10.1016/j.jad.2020.09.017] [Reference Citation Analysis]
186 Dowling NL, Bonwick R, Dharwadkar NP, Ng CH. Repetitive transcranial magnetic stimulation for major depression: A naturalistic observational study in an Australian private hospital. Psychiatry Research 2020;291:113275. [DOI: 10.1016/j.psychres.2020.113275] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
187 Pitsillou E, Liang J, Hung A, Karagiannis TC. The circadian machinery links metabolic disorders and depression: A review of pathways, proteins and potential pharmacological interventions. Life Sci 2021;265:118809. [PMID: 33249097 DOI: 10.1016/j.lfs.2020.118809] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
188 Tatsiopoulou P, Porfyri GN, Bonti E, Diakogiannis I. School Failure in a Girl with Specific Learning Difficulties, Suffering from Childhood Depression: Interdisciplinary Therapeutic Approach. Brain Sci 2020;10:E992. [PMID: 33339175 DOI: 10.3390/brainsci10120992] [Reference Citation Analysis]
189 Kwon CY, Lee B, Chung SY, Kim JW. Do Cochrane reviews reflect the latest evidence on meditation and mindfulness-based interventions? A snapshot of the current evidence. Explore (NY) 2021;17:557-65. [PMID: 32527685 DOI: 10.1016/j.explore.2020.05.016] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
190 Wyska E. Pharmacokinetic considerations for current state-of-the-art antidepressants. Expert Opinion on Drug Metabolism & Toxicology 2019;15:831-47. [DOI: 10.1080/17425255.2019.1669560] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
191 Ferguson W, Clapshaw L. Study of mental health outcomes associated with different brands of venlafaxine at the Kumeu medical centre from January 2017 to October 2018. Ther Adv Psychopharmacol 2020;10:2045125320927309. [PMID: 32547732 DOI: 10.1177/2045125320927309] [Reference Citation Analysis]
192 Greene M, Paladini L, Lemmer T, Piedade A, Touya M, Clark O. Systematic literature review on patterns of pharmacological treatment and adherence among patients with bipolar disorder type I in the USA. Neuropsychiatr Dis Treat 2018;14:1545-59. [PMID: 29950839 DOI: 10.2147/NDT.S166730] [Cited by in Crossref: 21] [Cited by in F6Publishing: 5] [Article Influence: 5.3] [Reference Citation Analysis]
193 Maj M, Stein DJ, Parker G, Zimmerman M, Fava GA, De Hert M, Demyttenaere K, McIntyre RS, Widiger T, Wittchen HU. The clinical characterization of the adult patient with depression aimed at personalization of management. World Psychiatry 2020;19:269-93. [PMID: 32931110 DOI: 10.1002/wps.20771] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 13.5] [Reference Citation Analysis]
194 Schubert KO, Thalamuthu A, Amare AT, Frank J, Streit F, Adl M, Akula N, Akiyama K, Ardau R, Arias B, Aubry JM, Backlund L, Bhattacharjee AK, Bellivier F, Benabarre A, Bengesser S, Biernacka JM, Birner A, Marie-Claire C, Cearns M, Cervantes P, Chen HC, Chillotti C, Cichon S, Clark SR, Cruceanu C, Czerski PM, Dalkner N, Dayer A, Degenhardt F, Del Zompo M, DePaulo JR, Étain B, Falkai P, Forstner AJ, Frisen L, Frye MA, Fullerton JM, Gard S, Garnham JS, Goes FS, Grigoroiu-Serbanescu M, Grof P, Hashimoto R, Hauser J, Heilbronner U, Herms S, Hoffmann P, Hou L, Hsu YH, Jamain S, Jiménez E, Kahn JP, Kassem L, Kuo PH, Kato T, Kelsoe J, Kittel-Schneider S, Ferensztajn-Rochowiak E, König B, Kusumi I, Laje G, Landén M, Lavebratt C, Leboyer M, Leckband SG, Maj M, Manchia M, Martinsson L, McCarthy MJ, McElroy S, Colom F, Mitjans M, Mondimore FM, Monteleone P, Nievergelt CM, Nöthen MM, Novák T, O'Donovan C, Ozaki N, Ösby U, Papiol S, Pfennig A, Pisanu C, Potash JB, Reif A, Reininghaus E, Rouleau GA, Rybakowski JK, Schalling M, Schofield PR, Schweizer BW, Severino G, Shekhtman T, Shilling PD, Shimoda K, Simhandl C, Slaney CM, Squassina A, Stamm T, Stopkova P, Tekola-Ayele F, Tortorella A, Turecki G, Veeh J, Vieta E, Witt SH, Roberts G, Zandi PP, Alda M, Bauer M, McMahon FJ, Mitchell PB, Schulze TG, Rietschel M, Baune BT; Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium. Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients. Transl Psychiatry 2021;11:606. [PMID: 34845190 DOI: 10.1038/s41398-021-01702-2] [Reference Citation Analysis]
195 Sajatovic M, DiBiasi F, Legacy SN. Attitudes toward antipsychotic treatment among patients with bipolar disorders and their clinicians: a systematic review. Neuropsychiatr Dis Treat 2017;13:2285-96. [PMID: 28919760 DOI: 10.2147/NDT.S139557] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
196 Malhi GS, Outhred T, Hamilton A, Boyce PM, Bryant R, Fitzgerald PB, Lyndon B, Mulder R, Murray G, Porter RJ, Singh AB, Fritz K. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders: major depression summary. Medical Journal of Australia 2018;208:175-80. [DOI: 10.5694/mja17.00659] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
197 Baldwin DS, Amaro HJF. Prescription of Valproate-Containing Medicines in Women of Childbearing Potential who have Psychiatric Disorders: Is It Worth the Risk? CNS Drugs 2020;34:163-9. [PMID: 31845215 DOI: 10.1007/s40263-019-00694-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
198 Oliva V, Lippi M, Paci R, Del Fabro L, Delvecchio G, Brambilla P, De Ronchi D, Fanelli G, Serretti A. Gastrointestinal side effects associated with antidepressant treatments in patients with major depressive disorder: A systematic review and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 2021;109:110266. [PMID: 33549697 DOI: 10.1016/j.pnpbp.2021.110266] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
199 Weightman M. Digital psychotherapy as an effective and timely treatment option for depression and anxiety disorders: Implications for rural and remote practice. J Int Med Res 2020;48:300060520928686. [PMID: 32527170 DOI: 10.1177/0300060520928686] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
200 Lea T, Amada N, Jungaberle H. Psychedelic Microdosing: A Subreddit Analysis. J Psychoactive Drugs 2020;52:101-12. [PMID: 31648596 DOI: 10.1080/02791072.2019.1683260] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
201 Fitzgerald PB, Gill S, Hussain S, Sarma S, Chamoli S, Weiss A, Garside D, Purushothaman S, Fasnacht M, Simpson B, Csizmadia T, Dean C, Loo C. The place of non-invasive brain stimulation in the RANZCP clinical practice guidelines for mood disorders. Aust N Z J Psychiatry 2021;55:349-54. [PMID: 33797285 DOI: 10.1177/00048674211004344] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
202 Taylor R, Galvez V, Loo C. Transcranial magnetic stimulation (TMS) safety: a practical guide for psychiatrists.Australas Psychiatry. 2018;26:189-192. [PMID: 29338288 DOI: 10.1177/1039856217748249] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 6.5] [Reference Citation Analysis]
203 Aran P, Lewis AJ, Watson SJ, Nguyen T, Galbally M. Emotional availability in women with bipolar disorder and major depression: A longitudinal pregnancy cohort study. Aust N Z J Psychiatry 2021;55:1079-88. [PMID: 33726546 DOI: 10.1177/0004867421998796] [Reference Citation Analysis]
204 Witt K, Potts J, Hubers A, Grunebaum MF, Murrough JW, Loo C, Cipriani A, Hawton K. Ketamine for suicidal ideation in adults with psychiatric disorders: A systematic review and meta-analysis of treatment trials. Aust N Z J Psychiatry 2020;54:29-45. [DOI: 10.1177/0004867419883341] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 12.0] [Reference Citation Analysis]
205 Pacchiarotti I, Anmella G, Colomer L, Vieta E. How to treat mania. Acta Psychiatr Scand 2020;142:173-92. [PMID: 33460070 DOI: 10.1111/acps.13209] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
206 Fountoulakis KN, Grunze H, Vieta E, Young A, Yatham L, Blier P, Kasper S, Moeller HJ. The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 3: The Clinical Guidelines. Int J Neuropsychopharmacol 2017;20:180-95. [PMID: 27941079 DOI: 10.1093/ijnp/pyw109] [Cited by in Crossref: 29] [Cited by in F6Publishing: 45] [Article Influence: 7.3] [Reference Citation Analysis]
207 Sanders A, Rackers H, Kimmel M. A role for the microbiome in mother–infant interaction and perinatal depression. International Review of Psychiatry 2019;31:280-94. [DOI: 10.1080/09540261.2018.1548431] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
208 Carnell BL, Clarke P, Gill S, Galletly CA. How effective is repetitive transcranial magnetic stimulation for bipolar depression? J Affect Disord 2017;209:270-2. [PMID: 27987405 DOI: 10.1016/j.jad.2016.11.041] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
209 Miljevic A, Bailey NW, Herring SE, Fitzgerald PB. Potential predictors of depressive relapse following repetitive Transcranial Magnetic Stimulation: A systematic review. J Affect Disord 2019;256:317-23. [PMID: 31201982 DOI: 10.1016/j.jad.2019.06.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
210 Hurley J, Lakeman R, Cashin A, Ryan T. Mental health nurse psychotherapists are well situated to improve service shortfalls in Australia: findings from a qualitative study. Australas Psychiatry 2020;28:423-5. [PMID: 32510981 DOI: 10.1177/1039856220924326] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
211 Kim JM, Stewart R, Kang HJ, Kim JW, Lee HJ, Jhon M, Lee JY, Kim SW, Shin IS. Predictors of relapse following a stepwise psychopharmacotherapy regime in patients with depressive disorders. J Affect Disord 2021;293:109-16. [PMID: 34175592 DOI: 10.1016/j.jad.2021.06.015] [Reference Citation Analysis]
212 Simões do Couto F, Lunet N, Ginó S, Chester C, Freitas V, Maruta C, Figueira ML, de Mendonça A. Depression with melancholic features is associated with higher long-term risk for dementia. J Affect Disord 2016;202:220-9. [PMID: 27267294 DOI: 10.1016/j.jad.2016.05.026] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
213 Schuch FB, Vancampfort D, Sui X, Rosenbaum S, Firth J, Richards J, Ward PB, Stubbs B. Are lower levels of cardiorespiratory fitness associated with incident depression? A systematic review of prospective cohort studies. Preventive Medicine 2016;93:159-65. [DOI: 10.1016/j.ypmed.2016.10.011] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 9.3] [Reference Citation Analysis]
214 Dols A, Kessing LV, Strejilevich SA, Rej S, Tsai S, Gildengers AG, Almeida OP, Shulman KI, Sajatovic M; The International Society for Bipolar Disorders Task Force for Older Adults with Bipolar Disorder. Do current national and international guidelines have specific recommendations for older adults with bipolar disorder? A brief report: Guidelines lack recommendations for OABD. Int J Geriatr Psychiatry 2016;31:1295-300. [DOI: 10.1002/gps.4534] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
215 Verdolini N, Hidalgo-Mazzei D, Murru A, Pacchiarotti I, Samalin L, Young AH, Vieta E, Carvalho AF. Mixed states in bipolar and major depressive disorders: systematic review and quality appraisal of guidelines. Acta Psychiatr Scand 2018;138:196-222. [PMID: 29756288 DOI: 10.1111/acps.12896] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 7.5] [Reference Citation Analysis]
216 De Crescenzo F, Garriga C, Tomlinson A, Coupland C, Efthimiou O, Fazel S, Hippisley-Cox J, Cipriani A. Real-world effect of antidepressants for depressive disorder in primary care: protocol of a population-based cohort study. Evid Based Ment Health 2020;23:122-6. [PMID: 32554440 DOI: 10.1136/ebmental-2020-300149] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
217 Chen R, Zhu X, Capitão LP, Zhang H, Luo J, Wang X, Xi Y, Song X, Feng Y, Cao L, Malhi GS. Psychoeducation for psychiatric inpatients following remission of a manic episode in bipolar I disorder: A randomized controlled trial. Bipolar Disord 2019;21:76-85. [PMID: 29578271 DOI: 10.1111/bdi.12642] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
218 Capon H, O'Shea M, Evans S, McIver S. Yoga complements cognitive behaviour therapy as an adjunct treatment for anxiety and depression: Qualitative findings from a mixed-methods study. Psychol Psychother 2021. [PMID: 33834599 DOI: 10.1111/papt.12343] [Reference Citation Analysis]
219 Nikolova VL, Pattanaseri K, Hidalgo-Mazzei D, Taylor D, Young AH. Is lithium monitoring NICE? Lithium monitoring in a UK secondary care setting. J Psychopharmacol 2018;32:408-15. [PMID: 29552933 DOI: 10.1177/0269881118760663] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
220 Kellner CH, Obbels J, Sienaert P. When to consider electroconvulsive therapy (ECT). Acta Psychiatr Scand 2020;141:304-15. [PMID: 31774547 DOI: 10.1111/acps.13134] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 8.3] [Reference Citation Analysis]
221 Cleare AJ. Guidelines to the guidelines. Bipolar Disord 2018. [PMID: 29956425 DOI: 10.1111/bdi.12671] [Reference Citation Analysis]
222 Keks NA, Hope J, Keogh S, Copolov DL. Milnacipran: serotonin-noradrenaline reuptake inhibitor approved for fibromyalgia may be a useful antidepressant. Australas Psychiatry 2018;26:537-40. [DOI: 10.1177/1039856218794874] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
223 Jessel CD, Mostafa S, Potiriadis M, Everall IP, Gunn JM, Bousman CA. Use of antidepressants with pharmacogenetic prescribing guidelines in a 10-year depression cohort of adult primary care patients. Pharmacogenetics and Genomics 2020;30:145-52. [DOI: 10.1097/fpc.0000000000000406] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
224 Reddy YJ, Jhanwar V, Nagpal R, Reddy M, Shah N, Ghorpade S, Kulkarni S. Prescribing practices of Indian psychiatrists in the treatment of bipolar disorder. Aust N Z J Psychiatry 2019;53:458-69. [DOI: 10.1177/0004867419826718] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
225 Lalley NA, Manger SH, Jacka F, Rocks T, Ruusunen A, Barron L. The Mind-Body Well-being Initiative: a better lifestyle for people with severe mental illness. Australas Psychiatry 2021;29:434-8. [PMID: 33472384 DOI: 10.1177/1039856220978864] [Reference Citation Analysis]
226 Yuan S, Zhou X, Zhang Y, Zhang H, Pu J, Yang L, Liu L, Jiang X, Xie P. Comparative efficacy and acceptability of bibliotherapy for depression and anxiety disorders in children and adolescents: a meta-analysis of randomized clinical trials. Neuropsychiatr Dis Treat 2018;14:353-65. [PMID: 29416337 DOI: 10.2147/NDT.S152747] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 2.8] [Reference Citation Analysis]
227 Gomes-da-Costa S, Marx W, Corponi F, Anmella G, Murru A, Pons-Cabrera MT, Giménez-Palomo A, Gutiérrez-Arango F, Llach CD, Fico G, Kotzalidis GD, Verdolini N, Valentí M, Berk M, Vieta E, Pacchiarotti I. Lithium therapy and weight change in people with bipolar disorder: A systematic review and meta-analysis. Neurosci Biobehav Rev 2021:S0149-7634(21)00310-9. [PMID: 34265322 DOI: 10.1016/j.neubiorev.2021.07.011] [Reference Citation Analysis]
228 Malhi GS, Bell E, Outhred T, Berk M. Lithium therapy and its interactions. Aust Prescr 2020;43:91-3. [PMID: 32675910 DOI: 10.18773/austprescr.2020.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
229 Morton E, Torous J, Murray G, Michalak EE. Using apps for bipolar disorder - An online survey of healthcare provider perspectives and practices. J Psychiatr Res 2021;137:22-8. [PMID: 33647725 DOI: 10.1016/j.jpsychires.2021.02.047] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
230 Ayub Dargél A, Masson M, Henry C. The RANZCP guidelines: Managing mood disorders in the real world. Aust N Z J Psychiatry 2016;50:1198-9. [PMID: 27789652 DOI: 10.1177/0004867416676373] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
231 Cotton SM, Berk M, Jackson H, Murray G, Filia K, Hasty M, Chanen A, Davey C, Nelson B, Ratheesh A, Macneil C. Improving functional outcomes in early‐stage bipolar disorder: The protocol for the REsearch into COgnitive and behavioural VERsatility trial. Early Intervention in Psychiatry 2019;13:1470-9. [DOI: 10.1111/eip.12797] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
232 Malhi GS, Morris G, Hamilton A, Outhred T, Das P. Defining the role of SGAs in the long-term treatment of bipolar disorder. Bipolar Disord 2017;19:65-7. [DOI: 10.1111/bdi.12472] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
233 Anmella G, Pacchiarotti I, Cubała WJ, Dudek D, Maina G, Thomas P, Vieta E. Expert advice on the management of valproate in women with bipolar disorder at childbearing age. Eur Neuropsychopharmacol 2019;29:1199-212. [PMID: 31590972 DOI: 10.1016/j.euroneuro.2019.09.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
234 Nederlof M, Kupka RW, Braam AM, Egberts A, Heerdink ER. Evaluation of clarity of presentation and applicability of monitoring instructions for patients using lithium in clinical practice guidelines for treatment of bipolar disorder. Bipolar Disord 2018;20:708-20. [PMID: 30105767 DOI: 10.1111/bdi.12681] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
235 Malhi GS, Byrow Y. Exercising control over bipolar disorder. Evid Based Ment Health 2016;19:103-5. [PMID: 27679680 DOI: 10.1136/eb-2016-102430] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
236 Nolen WA, Licht RW, Young AH, Malhi GS, Tohen M, Vieta E, Kupka RW, Zarate C, Nielsen RE, Baldessarini RJ, Severus E; ISBD/IGSLI Task Force on the treatment with lithium. What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD/IGSLI Task Force on treatment with lithium. Bipolar Disord 2019;21:394-409. [PMID: 31112628 DOI: 10.1111/bdi.12805] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 12.3] [Reference Citation Analysis]
237 Alvarez-grandi SA, Groves SJ, Douglas KM, Porter RJ. Systematic Monitoring of Cognitive Function During Electroconvulsive Therapy: A Retrospective Analysis of Data From a Service Using a Short Cognitive Testing Battery. J ECT 2020;36:10-7. [DOI: 10.1097/yct.0000000000000659] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
238 Goldspink R, Pumipi T, Dey S, Menkes DB. Sodium valproate prescription to women of childbearing age in a New Zealand inpatient psychiatric unit. Australas Psychiatry 2020;28:555-8. [PMID: 32586113 DOI: 10.1177/1039856220934317] [Reference Citation Analysis]
239 Mulder R, Hamilton A, Irwin L, Boyce P, Morris G, Porter RJ, Malhi GS. Treating depression with adjunctive antipsychotics. Bipolar Disord 2018;20:17-24. [DOI: 10.1111/bdi.12701] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
240 Ng CW, How CH, Ng YP. Managing depression in primary care. Singapore Med J 2017;58:459-66. [PMID: 28848991 DOI: 10.11622/smedj.2017080] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
241 Thomas R, Chur-hansen A, Turner M. A Systematic Review of Studies on the Use of Mindfulness-Based Cognitive Therapy for the Treatment of Anxiety and Depression in Older People. Mindfulness 2020;11:1599-609. [DOI: 10.1007/s12671-020-01336-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
242 Porter RJ. A year of guidelines: What have we learnt? Aust N Z J Psychiatry 2016;50:1121-2. [PMID: 27895231 DOI: 10.1177/0004867416680300] [Reference Citation Analysis]
243 Dargél AA, Godin O, Etain B, Hirakata V, Azorin J, M’bailara K, Bellivier F, Bougerol T, Kahn J, Passerieux C, Aubin V, Courtet P, Leboyer M, Henry C; on behalf of the FACE-BD collaborators. Emotional reactivity, functioning, and C-reactive protein alterations in remitted bipolar patients: Clinical relevance of a dimensional approach. Aust N Z J Psychiatry 2017;51:788-98. [DOI: 10.1177/0004867417691850] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
244 Lobban F, Dodd AL, Sawczuk AP, Asar O, Dagnan D, Diggle PJ, Griffiths M, Honary M, Knowles D, Long R, Morriss R, Parker R, Jones S. Assessing Feasibility and Acceptability of Web-Based Enhanced Relapse Prevention for Bipolar Disorder (ERPonline): A Randomized Controlled Trial. J Med Internet Res 2017;19:e85. [PMID: 28341619 DOI: 10.2196/jmir.7008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
245 Rakitin A. Why Do Psychiatrists Still Prescribe Valproate to Women of Childbearing Potential? Front Psychiatry 2020;11:739. [PMID: 32848919 DOI: 10.3389/fpsyt.2020.00739] [Reference Citation Analysis]
246 Malhi GS. Management Commentary. In: Parker G, editor. Bipolar II Disorder. Cambridge University Press; 2018. pp. 242-5. [DOI: 10.1017/9781108333252.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
247 Kim HS, Youn T, Kim SH, Jeong SH, Jung HY, Jeong S, Kim KK, Kim YS, Chung IW. Association between electroencephalogram changes and plasma clozapine levels in clozapine-treated patients: . International Clinical Psychopharmacology 2019;34:131-7. [DOI: 10.1097/yic.0000000000000255] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
248 Morton E, Michalak EE, Hole R, Buzwell S, Murray G. ‘Taking back the reins’ – A qualitative study of the meaning and experience of self-management in bipolar disorder. Journal of Affective Disorders 2018;228:160-5. [DOI: 10.1016/j.jad.2017.12.018] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
249 Singh AB, Baune BT, Hamilton A, Das P, Outhred T, Morris G, Bassett D, Berk M, Boyce P, Lyndon B, Mulder R, Parker G, Malhi GS. Psychotropic pharmacogenetics - Distraction or destiny? Aust N Z J Psychiatry 2017;51:665-7. [PMID: 28633577 DOI: 10.1177/0004867417715687] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
250 Päivärinne V, Thodén M, Kautiainen H, Arokoski J, Koponen H, Heinonen A, Kiviranta I. Physical activity and ability to meet different work requirements among adult working men with or without current depressive symptoms. Int Arch Occup Environ Health 2021;94:451-8. [PMID: 33125526 DOI: 10.1007/s00420-020-01595-6] [Reference Citation Analysis]
251 Bobo WV, Riva-Posse P, Goes FS, Parikh SV. Next-Step Treatment Considerations for Patients With Treatment-Resistant Depression That Responds to Low-Dose Intravenous Ketamine. Focus (Am Psychiatr Publ) 2020;18:181-92. [PMID: 33162856 DOI: 10.1176/appi.focus.20190048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
252 Shim IH, Woo YS, Kim MD, Bahk WM. Antidepressants and Mood Stabilizers: Novel Research Avenues and Clinical Insights for Bipolar Depression. Int J Mol Sci 2017;18:E2406. [PMID: 29137178 DOI: 10.3390/ijms18112406] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
253 Dome P, Tombor L, Lazary J, Gonda X, Rihmer Z. Natural health products, dietary minerals and over-the-counter medications as add-on therapies to antidepressants in the treatment of major depressive disorder: a review. Brain Research Bulletin 2019;146:51-78. [DOI: 10.1016/j.brainresbull.2018.12.015] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
254 Rush AJ, Aaronson ST, Demyttenaere K. Difficult-to-treat depression: A clinical and research roadmap for when remission is elusive. Aust N Z J Psychiatry 2019;53:109-18. [PMID: 30378447 DOI: 10.1177/0004867418808585] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
255 Lew SY, Teoh SL, Lim SH, Lim LW, Wong KH. Discovering the Potentials of Medicinal Mushrooms in Combating Depression - A Review. Mini Rev Med Chem 2020;20:1518-31. [PMID: 32452327 DOI: 10.2174/1389557520666200526125534] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
256 Di Salvo G, Maina G, Pessina E, Teobaldi E, Barbaro F, Martini A, Albert U, Rosso G. Aripiprazole Augmentation to Mood Stabilizers for Obsessive-Compulsive Symptoms in Bipolar Disorder. Medicina (Kaunas) 2020;57:9. [PMID: 33374357 DOI: 10.3390/medicina57010009] [Reference Citation Analysis]
257 Ashton MM, Berk M, Ng CH, Hopwood M, Kavanagh B, Williams LJ, Sarris J, Dean OM. Nutraceuticals and nutritional supplements for the treatment of bipolar disorder: protocol for a systematic review. BMJ Open 2019;9:e025640. [PMID: 30948585 DOI: 10.1136/bmjopen-2018-025640] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
258 Indraratna P, Tardo D, Delves M, Szirt R, Ng B. Measurement and Management of QT Interval Prolongation for General Physicians. J Gen Intern Med 2020;35:865-73. [PMID: 31654357 DOI: 10.1007/s11606-019-05477-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
259 Groves SJ, Douglas KM, Porter RJ. A Systematic Review of Cognitive Predictors of Treatment Outcome in Major Depression. Front Psychiatry 2018;9:382. [PMID: 30210368 DOI: 10.3389/fpsyt.2018.00382] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 6.8] [Reference Citation Analysis]
260 Tavares DF, Myczkowski ML, Alberto RL, Valiengo L, Rios RM, Gordon P, de Sampaio-Junior B, Klein I, Mansur CG, Marcolin MA, Lafer B, Moreno RA, Gattaz W, Daskalakis ZJ, Brunoni AR. Treatment of Bipolar Depression with Deep TMS: Results from a Double-Blind, Randomized, Parallel Group, Sham-Controlled Clinical Trial. Neuropsychopharmacology 2017;42:2593-601. [PMID: 28145409 DOI: 10.1038/npp.2017.26] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 7.6] [Reference Citation Analysis]
261 Taylor R, Hadzi-pavlovic D, Nikolin S, Bull M, Wark H, Leyden J, Harper S, Martin D, Galvez V, Loo C. The anaesthetic-ECT time interval with thiopentone—Impact on seizure quality. Journal of Affective Disorders 2019;252:135-40. [DOI: 10.1016/j.jad.2019.04.027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
262 Shawyer F, Enticott JC, Özmen M, Inder B, Meadows GN. Mindfulness-based cognitive therapy for recurrent major depression: A 'best buy' for health care? Aust N Z J Psychiatry 2016;50:1001-13. [PMID: 27095791 DOI: 10.1177/0004867416642847] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
263 Niethe M, Whitfield K. Psychotropic medication use during pregnancy. J Pharm Pract Res 2018;48:384-91. [DOI: 10.1002/jppr.1483] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
264 Morton E, Murray G, Michalak EE, Lam RW, Beaulieu S, Sharma V, Cervantes P, Parikh SV, Yatham LN. Quality of life in bipolar disorder: towards a dynamic understanding. Psychol Med 2018;48:1111-8. [PMID: 28918761 DOI: 10.1017/S0033291717002495] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
265 Chan SHW, Tse S, Chung KF, Yu CH, Chung RCK, Lo HHM. The effect of a brief mindfulness-based intervention on personal recovery in people with bipolar disorder: a randomized controlled trial (study protocol). BMC Psychiatry 2019;19:255. [PMID: 31438925 DOI: 10.1186/s12888-019-2242-0] [Reference Citation Analysis]
266 Belzeaux R, Sanguinetti C, Murru A, Verdolini N, Pacchiarotti I, Hidalgo-Mazzei D, Cohen L, Anmella G, Barbuti M, Vieta E, Llorca PM, Samalin L. Pharmacotherapy for the peripartum management of bipolar disorder. Expert Opin Pharmacother 2019;20:1731-41. [PMID: 31159601 DOI: 10.1080/14656566.2019.1626826] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
267 Henry C, Godin O, Courtet P, Azorin J, Gard S, Bellivier F, Polosan M, Kahn J, Roux P, Aubin V, Costagliola D, Leboyer M, Etain B; the FACE-BD collaborators. Outcomes for bipolar patients assessed in the French expert center network: A 2-year follow-up observational study (FondaMental Advanced Centers of Expertise for Bipolar Disorder [FACE-BD]). Bipolar Disord 2017;19:651-60. [DOI: 10.1111/bdi.12539] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
268 Choi W, Kim JW, Kang HJ, Kim HK, Kang HC, Lee JY, Kim SW, Stewart R, Kim JM. Interaction effect of serum serotonin level and age on the 12-week pharmacotherapeutic response in patients with depressive disorders. Sci Rep 2021;11:24226. [PMID: 34930976 DOI: 10.1038/s41598-021-03753-3] [Reference Citation Analysis]
269 Geoffroy PA, Etain B. Lithium and Circadian Rhythms. In: Malhi GS, Masson M, Bellivier F, editors. The Science and Practice of Lithium Therapy. Cham: Springer International Publishing; 2017. pp. 111-24. [DOI: 10.1007/978-3-319-45923-3_6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
270 Dawson SL, Dash SR, Jacka FN. The Importance of Diet and Gut Health to the Treatment and Prevention of Mental Disorders. Int Rev Neurobiol 2016;131:325-46. [PMID: 27793225 DOI: 10.1016/bs.irn.2016.08.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
271 Saragoussi D, Christensen MC, Hammer-Helmich L, Rive B, Touya M, Haro JM. Long-term follow-up on health-related quality of life in major depressive disorder: a 2-year European cohort study. Neuropsychiatr Dis Treat 2018;14:1339-50. [PMID: 29872301 DOI: 10.2147/NDT.S159276] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 5.8] [Reference Citation Analysis]
272 Fisher A, Sharpe L, Costa D, Anderson J, Manicavasagar V, Juraskova I. Phase II Randomised Controlled Trial of a patient decision-aid website to improve treatment decision-making for young adults with bipolar II disorder: A feasibility study protocol. Contemp Clin Trials Commun 2018;12:137-44. [PMID: 30456328 DOI: 10.1016/j.conctc.2018.11.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
273 Dogan E, Sander C, Wagner X, Hegerl U, Kohls E. Smartphone-Based Monitoring of Objective and Subjective Data in Affective Disorders: Where Are We and Where Are We Going? Systematic Review. J Med Internet Res 2017;19:e262. [PMID: 28739561 DOI: 10.2196/jmir.7006] [Cited by in Crossref: 86] [Cited by in F6Publishing: 58] [Article Influence: 17.2] [Reference Citation Analysis]
274 Hill H. Is it time to include people with intellectual disabilities in Royal Australian and New Zealand College of Psychiatrists’ treatment guidelines? Australas Psychiatry 2019;27:519-21. [DOI: 10.1177/1039856219848834] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
275 Haskey C, Galbally M. Mood stabilizers in pregnancy and child developmental outcomes: A systematic review. Aust N Z J Psychiatry 2017;51:1087-97. [PMID: 28825316 DOI: 10.1177/0004867417726175] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
276 Carter G, Sperandei S, Chitty KM, Page A. Antidepressant treatment trajectories and suicide attempt among Australians aged 45 years and older: A population study using individual prescription data. Suicide Life Threat Behav 2021. [PMID: 34693551 DOI: 10.1111/sltb.12812] [Reference Citation Analysis]
277 Choi W, Kang HJ, Kim JW, Kim HK, Kang HC, Lee JY, Kim SW, Stewart R, Kim JM. Predictive values of tumor necrosis factor-α for depression treatment outcomes: effect modification by hazardous alcohol consumption. Transl Psychiatry 2021;11:450. [PMID: 34475376 DOI: 10.1038/s41398-021-01581-7] [Reference Citation Analysis]
278 Crowe M, Inder M. Staying well with bipolar disorder: A qualitative analysis of five-year follow-up interviews with young people. J Psychiatr Ment Health Nurs 2018;25:236-44. [DOI: 10.1111/jpm.12455] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
279 Malhi GS, Bell E, Bassett D, Boyce P, Bryant R, Hazell P, Hopwood M, Lyndon B, Mulder R, Porter R, Singh AB, Murray G. The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry 2021;55:7-117. [PMID: 33353391 DOI: 10.1177/0004867420979353] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 52.0] [Reference Citation Analysis]
280 Beaglehole B, Moor S, Zhang T, Hamilton GJ, Mulder RT, Boden JM, Frampton CMA, Bell CJ. Impact of the Canterbury earthquakes on dispensing of psychiatric medication for children and adolescents: longitudinal quantitative study. Br J Psychiatry 2020;216:151-5. [PMID: 31992378 DOI: 10.1192/bjp.2019.273] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
281 Jazzar U, Bergerot CD, Shan Y, Wallis CJD, Freedland SJ, Kamat AM, Tyler DS, Baillargeon J, Kuo YF, Klaassen Z, Williams SB. Use of psychotropic drugs among older patients with bladder cancer in the United States. Psychooncology 2021;30:832-43. [PMID: 33507622 DOI: 10.1002/pon.5641] [Reference Citation Analysis]
282 Bayes A, Parker G. How to choose an antidepressant medication. Acta Psychiatr Scand 2019;139:280-91. [DOI: 10.1111/acps.13001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
283 Malhi GS, Byrow Y, Bassett D, Boyce P, Hopwood M, Lyndon W, Mulder R, Porter R, Singh A, Murray G. Stimulants for depression: On the up and up? Aust N Z J Psychiatry 2016;50:203-7. [DOI: 10.1177/0004867416634208] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
284 Kelly T. Lithium and the Woozle effect. Bipolar Disord 2019;21:302-8. [DOI: 10.1111/bdi.12753] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
285 Xiong J, Lipsitz O, Chen-Li D, Rosenblat JD, Rodrigues NB, Carvalho I, Lui LMW, Gill H, Narsi F, Mansur RB, Lee Y, McIntyre RS. The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis. J Psychiatr Res 2021;134:57-68. [PMID: 33360864 DOI: 10.1016/j.jpsychires.2020.12.038] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
286 Karrouri R, Hammani Z, Benjelloun R, Otheman Y. Major depressive disorder: Validated treatments and future challenges. World J Clin Cases 2021; 9(31): 9350-9367 [PMID: 34877271 DOI: 10.12998/wjcc.v9.i31.9350] [Reference Citation Analysis]
287 Morton E, Murray G. Assessment and treatment of sleep problems in bipolar disorder—A guide for psychologists and clinically focused review. Clin Psychol Psychother 2020;27:364-77. [DOI: 10.1002/cpp.2433] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
288 Malhi GS, Bell E, Boyce P, Bassett D, Berk M, Bryant R, Gitlin M, Hamilton A, Hazell P, Hopwood M, Lyndon B, Mcintyre RS, Morris G, Mulder R, Porter R, Singh AB, Yatham LN, Young A, Murray G. The 2020 Royal Australian and New Zealand College of psychiatrists clinical practice guidelines for mood disorders: Bipolar disorder summary. Bipolar Disord 2020;22:805-21. [DOI: 10.1111/bdi.13036] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
289 Douglas KM, Groves S, Crowe MT, Inder ML, Jordan J, Carlyle D, Wells H, Beaglehole B, Mulder R, Lacey C, Luty SE, Eggleston K, Frampton CMA, Bowie CR, Porter RJ. A randomised controlled trial of psychotherapy and cognitive remediation to target cognition in mood disorders. Acta Psychiatr Scand 2021. [PMID: 34800298 DOI: 10.1111/acps.13387] [Reference Citation Analysis]
290 Geoffroy PA, Bellivier F. The RANZCP mood disorders guidelines: An easy step-by-step toolbox for daily practice. Aust N Z J Psychiatry 2016;50:1014-5. [DOI: 10.1177/0004867416667829] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
291 Yalin N, Young AH. Pharmacological Treatment of Bipolar Depression: What are the Current and Emerging Options? Neuropsychiatr Dis Treat 2020;16:1459-72. [PMID: 32606699 DOI: 10.2147/NDT.S245166] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
292 Konno Y, Fujino Y, Ikenouchi A, Adachi N, Kubota Y, Azekawa T, Ueda H, Edagawa K, Katsumoto E, Goto E, Hongo S, Kato M, Tsuboi T, Yasui-Furukori N, Nakagawa A, Kikuchi T, Watanabe K, Yoshimura R. Relationship Between Mood Episode and Employment Status of Outpatients with Bipolar Disorder: Retrospective Cohort Study from the Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Clinics (MUSUBI) Project. Neuropsychiatr Dis Treat 2021;17:2867-76. [PMID: 34522098 DOI: 10.2147/NDT.S322507] [Reference Citation Analysis]
293 Lee Y, Brietzke E, Cao B, Chen Y, Linnaranta O, Mansur RB, Cortes P, Kösters M, Majeed A, Tamura JK, Lui LMW, Vinberg M, Keinänen J, Kisely S, Naveed S, Barbui C, Parker G, Owolabi M, Nishi D, Lee J, Srisurapanont M, Gill H, Guo L, Balanzá-Martínez V, Partonen T, Nolen WA, Lee JH, Kim JH, Chavannes NH, Ewais T, Atienza-Carbonell B, Silven AV, Yasuma N, Gil A, Novikov A, Lacey C, Versluis A, von Malortie S, Chan LF, Waqas A, Purgato M, Aardoom JJ, Ly-Uson JT, Sim K, Tuineag M, van der Kleij RMJJ, van Luenen S, Suttajit S, Hajek T, Lee YW, Porter RJ, Alsuwaidan M, Rosenblat JD, Ravindran AV, Lam RW, McIntyre RS; Global Alliance for Chronic Diseases (GACD) Mental Health Guidelines Working Group. Development and implementation of guidelines for the management of depression: a systematic review. Bull World Health Organ 2020;98:683-697H. [PMID: 33177758 DOI: 10.2471/BLT.20.251405] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
294 Malhi GS, Mann JJ. Depression. Lancet. 2018;392:2299-2312. [PMID: 30396512 DOI: 10.1016/s0140-6736(18)31948-2] [Cited by in Crossref: 465] [Cited by in F6Publishing: 207] [Article Influence: 116.3] [Reference Citation Analysis]
295 Schuch FB, Stubbs B. The Role of Exercise in Preventing and Treating Depression: . Current Sports Medicine Reports 2019;18:299-304. [DOI: 10.1249/jsr.0000000000000620] [Cited by in Crossref: 32] [Cited by in F6Publishing: 13] [Article Influence: 10.7] [Reference Citation Analysis]
296 Bousman CA, Arandjelovic K, Mancuso SG, Eyre HA, Dunlop BW. Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomized controlled trials. Pharmacogenomics 2019;20:37-47. [DOI: 10.2217/pgs-2018-0142] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 20.3] [Reference Citation Analysis]
297 Galletly C, Castle D, Dark F, Humberstone V, Jablensky A, Killackey E, Kulkarni J, McGorry P, Nielssen O, Tran N. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders. Aust N Z J Psychiatry. 2016;50:410-472. [PMID: 27106681 DOI: 10.1177/0004867416641195] [Cited by in Crossref: 354] [Cited by in F6Publishing: 286] [Article Influence: 70.8] [Reference Citation Analysis]
298 Grenyer BF, Ng FY, Townsend ML, Rao S. Personality disorder: A mental health priority area. Aust N Z J Psychiatry 2017;51:872-5. [DOI: 10.1177/0004867417717798] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
299 Carter G, Page A, Large M, Hetrick S, Milner AJ, Bendit N, Walton C, Draper B, Hazell P, Fortune S, Burns J, Patton G, Lawrence M, Dadd L, Robinson J, Christensen H. Royal Australian and New Zealand College of Psychiatrists clinical practice guideline for the management of deliberate self-harm. Aust N Z J Psychiatry 2016;50:939-1000. [DOI: 10.1177/0004867416661039] [Cited by in Crossref: 77] [Cited by in F6Publishing: 57] [Article Influence: 12.8] [Reference Citation Analysis]
300 Stevenson J, Haliburn J, Halovic S, Korner A, Mclean L. Mobilizing self through short-term dynamic interpersonal psychotherapy: a preliminary report. Psychoanalytic Psychotherapy 2019;32:351-67. [DOI: 10.1080/02668734.2018.1558415] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
301 Andrews G, Hobbs MJ. Pragmatic treatment options for depression and anxiety disorders are needed. World Psychiatry 2016;15:241-2. [PMID: 27717253 DOI: 10.1002/wps.20364] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
302 Gottlieb JF, Benedetti F, Geoffroy PA, Henriksen TEG, Lam RW, Murray G, Phelps J, Sit D, Swartz HA, Crowe M, Etain B, Frank E, Goel N, Haarman BCM, Inder M, Kallestad H, Jae Kim S, Martiny K, Meesters Y, Porter R, Riemersma-van der Lek RF, Ritter PS, Schulte PFJ, Scott J, Wu JC, Yu X, Chen S. The chronotherapeutic treatment of bipolar disorders: A systematic review and practice recommendations from the ISBD task force on chronotherapy and chronobiology. Bipolar Disord 2019;21:741-73. [PMID: 31609530 DOI: 10.1111/bdi.12847] [Cited by in Crossref: 58] [Cited by in F6Publishing: 41] [Article Influence: 19.3] [Reference Citation Analysis]
303 Murray G, Leitan ND, Thomas N, Michalak EE, Johnson SL, Jones S, Perich T, Berk L, Berk M. Towards recovery-oriented psychosocial interventions for bipolar disorder: Quality of life outcomes, stage-sensitive treatments, and mindfulness mechanisms. Clinical Psychology Review 2017;52:148-63. [DOI: 10.1016/j.cpr.2017.01.002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
304 Wilhelm K. Judging a book by its cover: Changing ‘treatment resistant’ to ‘difficult-to-treat’ depression. Aust N Z J Psychiatry 2019;53:101-3. [DOI: 10.1177/0004867419827644] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
305 Gitlin M. Lithium side effects and toxicity: prevalence and management strategies. Int J Bipolar Disord 2016;4:27. [PMID: 27900734 DOI: 10.1186/s40345-016-0068-y] [Cited by in Crossref: 137] [Cited by in F6Publishing: 102] [Article Influence: 22.8] [Reference Citation Analysis]
306 Hunt GE, Malhi GS, Cleary M, Lai HMX, Sitharthan T. Prevalence of comorbid bipolar and substance use disorders in clinical settings, 1990–2015: Systematic review and meta-analysis. Journal of Affective Disorders 2016;206:331-49. [DOI: 10.1016/j.jad.2016.07.011] [Cited by in Crossref: 77] [Cited by in F6Publishing: 62] [Article Influence: 12.8] [Reference Citation Analysis]
307 Fitzgerald PB, Gill S, Breakspear M, Kulkarni J, Chen L, Pridmore S, Purushothaman S, Galletly C, Clarke P, Ng F, Hussain S, Chamoli S, Csizmadia T, Tolan P, Cocchi L, Ibrahim Oam S, Shankar K, Sarma S, Lau M, Loo C, Yadav T, Hoy KE. Revisiting the effectiveness of repetitive transcranial magnetic stimulation treatment in depression, again. Aust N Z J Psychiatry 2021;:48674211068788. [PMID: 34969310 DOI: 10.1177/00048674211068788] [Reference Citation Analysis]
308 Malhi GS. Individualising therapy using individual participant data. The Lancet Psychiatry 2017;4:823-4. [DOI: 10.1016/s2215-0366(17)30370-x] [Cited by in Crossref: 6] [Article Influence: 1.2] [Reference Citation Analysis]
309 Ramanuj P, Ferenchick EK, Pincus HA. Depression in primary care: part 2-management. BMJ. 2019;365:l835. [PMID: 30962249 DOI: 10.1136/bmj.l835] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
310 Malhi GS, Gershon S, Outhred T. Lithiumeter: Version 2.0. Bipolar Disord 2016;18:631-41. [DOI: 10.1111/bdi.12455] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
311 Ashton MM, Dean OM, Marx W, Mohebbi M, Berk M, Malhi GS, Ng CH, Cotton SM, Dodd S, Sarris J, Hopwood M, Faye-Chauhan K, Kim Y, Dash SR, Jacka FN, Shivappa N, Hebert JR, Turner A. Diet quality, dietary inflammatory index and body mass index as predictors of response to adjunctive N-acetylcysteine and mitochondrial agents in adults with bipolar disorder: A sub-study of a randomised placebo-controlled trial. Aust N Z J Psychiatry 2020;54:159-72. [PMID: 31661974 DOI: 10.1177/0004867419882497] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
312 Sharma R, Alla K, Pfeffer D, Meurk C, Ford P, Kisely S, Gartner C. An appraisal of practice guidelines for smoking cessation in people with severe mental illness. Aust N Z J Psychiatry 2017;51:1106-20. [DOI: 10.1177/0004867417726176] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
313 Mullen S. Major depressive disorder in children and adolescents. Ment Health Clin. 2018;8:275-283. [PMID: 30397569 DOI: 10.9740/mhc.2018.11.275] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 6.5] [Reference Citation Analysis]
314 Elbakary N, Ouanes S, Riaz S, Abdallah O, Mahran I, Al-Khuzaei N, Eltorki Y. Prevalence, median time, and associated factors with the likelihood of initial antidepressant change: a cross-sectional study in Qatar. BMC Psychiatry 2021;21:115. [PMID: 33618690 DOI: 10.1186/s12888-021-03099-0] [Reference Citation Analysis]
315 Woolf BAR, Williams JVA, Lavorato DH, Bulloch AGM, Patten SB. A comparison of recommendations and received treatment for mood and anxiety disorders in a representative national sample. BMC Psychiatry 2017;17:155. [PMID: 28464808 DOI: 10.1186/s12888-017-1316-0] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
316 Shinohara K, Efthimiou O, Ostinelli EG, Tomlinson A, Geddes JR, Nierenberg AA, Ruhe HG, Furukawa TA, Cipriani A. Comparative efficacy and acceptability of antidepressants in the long-term treatment of major depression: protocol for a systematic review and networkmeta-analysis. BMJ Open 2019;9:e027574. [PMID: 31110100 DOI: 10.1136/bmjopen-2018-027574] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
317 Kulkarni J. Pharmacogenomics in psychiatry - Clinical innovation utilised by the Therapeutic Goods Administration and Food and Drug Administration. Aust N Z J Psychiatry 2017;51:93-4. [PMID: 27609939 DOI: 10.1177/0004867416667233] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
318 Czarnecka K, Chuchmacz J, Wójtowicz P, Szymański P. Memantine in neurological disorders - schizophrenia and depression. J Mol Med (Berl) 2021;99:327-34. [PMID: 33447926 DOI: 10.1007/s00109-020-01982-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
319 Harrison PJ, Cipriani A, Harmer CJ, Nobre AC, Saunders K, Goodwin GM, Geddes JR. Innovative approaches to bipolar disorder and its treatment. Ann N Y Acad Sci 2016;1366:76-89. [PMID: 27111134 DOI: 10.1111/nyas.13048] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 10.0] [Reference Citation Analysis]
320 Gitlin MJ. The CANMAT guidelines for bipolar disorder. Bipolar Disord 2018;20:275-6. [PMID: 29600547 DOI: 10.1111/bdi.12647] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
321 Verdolini N, Hidalgo-Mazzei D, Del Matto L, Muscas M, Pacchiarotti I, Murru A, Samalin L, Aedo A, Tohen M, Grunze H, Young AH, Carvalho AF, Vieta E. Long-term treatment of bipolar disorder type I: A systematic and critical review of clinical guidelines with derived practice algorithms. Bipolar Disord 2021;23:324-40. [PMID: 33354842 DOI: 10.1111/bdi.13040] [Reference Citation Analysis]
322 Inder M, Lacey C, Crowe M. Participation in decision-making about medication: A qualitative analysis of medication adherence. Int J Mental Health Nurs 2019;28:181-9. [DOI: 10.1111/inm.12516] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
323 Schuch F, Dunn A, Kanitz A, Delevatti R, Fleck M. Moderators of response in exercise treatment for depression: A systematic review. Journal of Affective Disorders 2016;195:40-9. [DOI: 10.1016/j.jad.2016.01.014] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 6.7] [Reference Citation Analysis]
324 Xiao L, Zhu X, Gillespie A, Feng Y, Zhou J, Chen X, Gao Y, Wang X, Ma X, Gao C, Xie Y, Pan X, Bai Y, Xu X, Wang G, Chen R. Effectiveness of mirtazapine as add-on to paroxetine v. paroxetine or mirtazapine monotherapy in patients with major depressive disorder with early non-response to paroxetine: a two-phase, multicentre, randomized, double-blind clinical trial. Psychol Med 2021;51:1166-74. [PMID: 31931894 DOI: 10.1017/S0033291719004069] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
325 Horgan D, Malhi GS. Intensive suicide prevention: Provide Intensive Contact and Start 2 antidepressants. Aust N Z J Psychiatry 2018;52:1023-5. [PMID: 30293455 DOI: 10.1177/0004867418805563] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
326 Dean OM, Gliddon E, Van Rheenen TE, Giorlando F, Davidson SK, Kaur M, Ngo TT, Williams LJ. An update on adjunctive treatment options for bipolar disorder.Bipolar Disord. 2018;20:87-96. [PMID: 29369487 DOI: 10.1111/bdi.12601] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
327 Stacey D, Schubert KO, Clark SR, Amare AT, Milanesi E, Maj C, Leckband SG, Shekhtman T, Kelsoe JR, Gurwitz D, Baune BT. A gene co-expression module implicating the mitochondrial electron transport chain is associated with long-term response to lithium treatment in bipolar affective disorder. Transl Psychiatry 2018;8:183. [PMID: 30185780 DOI: 10.1038/s41398-018-0237-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
328 Łojko D, Owecki M, Suwalska A. Impaired Glucose Metabolism in Bipolar Patients: The Role of Psychiatrists in Its Detection and Management. Int J Environ Res Public Health 2019;16:E1132. [PMID: 30934836 DOI: 10.3390/ijerph16071132] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
329 Malhi GS, Morris G, Bell E, Hamilton A. A New Paradigm for Achieving a Rapid Antidepressant Response. Drugs 2020;80:755-64. [PMID: 32347475 DOI: 10.1007/s40265-020-01303-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
330 Howells K, Lucassen M. ‘Post-Olympic blues’ –The diminution of celebrity in Olympic athletes. Psychology of Sport and Exercise 2018;37:67-78. [DOI: 10.1016/j.psychsport.2018.04.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
331 Takao Y, Figueroa E, Berna KFJ, Jo Y, Kissane LA, Yoshimura K, Tranter R, Porter RJ. Validation of a novel online depression symptom severity rating scale: the R8 Depression. Health Qual Life Outcomes 2021;19:163. [PMID: 34118932 DOI: 10.1186/s12955-020-01654-z] [Reference Citation Analysis]
332 Cavic E, Valle S, Chamberlain SR, Grant JE. Sleep quality and its clinical associations in trichotillomania and skin picking disorder. Compr Psychiatry 2021;105:152221. [PMID: 33395591 DOI: 10.1016/j.comppsych.2020.152221] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
333 Shaw J, Sethi S, Vaccaro L, Beatty L, Kirsten L, Kissane D, Kelly B, Mitchell G, Sherman K, Turner J. Is care really shared? A systematic review of collaborative care (shared care) interventions for adult cancer patients with depression. BMC Health Serv Res. 2019;19:120. [PMID: 30764822 DOI: 10.1186/s12913-019-3946-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
334 Bryson EO, Aloysi AS, Farber KG, Kellner CH. Individualized Anesthetic Management for Patients Undergoing Electroconvulsive Therapy: A Review of Current Practice. Anesthesia & Analgesia 2017;124:1943-56. [DOI: 10.1213/ane.0000000000001873] [Cited by in Crossref: 21] [Cited by in F6Publishing: 4] [Article Influence: 4.2] [Reference Citation Analysis]
335 Malhi GS. CEQUEL the sequel: bipolar disorder combination therapy. Lancet Psychiatry 2016;3:2-3. [PMID: 26687299 DOI: 10.1016/S2215-0366(15)00520-9] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
336 Malhi GS, Berk M, Morris G, Hamilton A, Outhred T, Das P, Bassett D, Baune BT, Boyce P, Lyndon B, Mulder R, Parker G, Singh AB. Mixed mood: The not so united states? Bipolar Disord 2017;19:242-5. [DOI: 10.1111/bdi.12502] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
337 Fairbrother F, Petzl N, Scott JG, Kisely S. Lithium can cause hyperthyroidism as well as hypothyroidism: A systematic review of an under-recognised association. Aust N Z J Psychiatry 2019;53:384-402. [DOI: 10.1177/0004867419833171] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
338 Phelps AJ, Lethbridge R, Brennan S, Bryant RA, Burns P, Cooper JA, Forbes D, Gardiner J, Gee G, Jones K, Kenardy J, Kulkarni J, McDermott B, McFarlane AC, Newman L, Varker T, Worth C, Silove D. Australian guidelines for the prevention and treatment of posttraumatic stress disorder: Updates in the third edition. Aust N Z J Psychiatry 2021;:48674211041917. [PMID: 34448406 DOI: 10.1177/00048674211041917] [Reference Citation Analysis]
339 Hess CW, Karter J, Cosgrove L, Hayden L. Evidence-based practice: a comparison of International Clinical Practice Guidelines and current research on physical activity for mild to moderate depression. Transl Behav Med 2019;9:703-10. [PMID: 30321410 DOI: 10.1093/tbm/iby092] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
340 Bauer M, Severus E, Möller H, Young AH; WFSBP Task Force on Unipolar Depressive Disorders. Pharmacological treatment of unipolar depressive disorders: summary of WFSBP guidelines. International Journal of Psychiatry in Clinical Practice 2017;21:166-76. [DOI: 10.1080/13651501.2017.1306082] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 9.8] [Reference Citation Analysis]
341 Uguz F, Kirkas A. Olanzapine and quetiapine in the prevention of a new mood episode in women with bipolar disorder during the postpartum period: a retrospective cohort study. Braz J Psychiatry 2021;43:617-20. [PMID: 33825764 DOI: 10.1590/1516-4446-2020-1629] [Reference Citation Analysis]
342 Malhi GS, Hamilton A, Morris G, Das P, Outhred T. Optimisation of adherence and discontinuation practices for maintenance antidepressant therapy. Aust N Z J Psychiatry 2017;51:403-5. [DOI: 10.1177/0004867417700987] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
343 Corponi F, Fabbri C, Serretti A. Pharmacogenetics and Depression: A Critical Perspective. Psychiatry Investig 2019;16:645-53. [PMID: 31455064 DOI: 10.30773/pi.2019.06.16] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
344 Malhi GS, Bell E, Mannie Z, Bassett D, Boyce P, Hopwood M, Mulder R, Porter RJ, Singh AB, Lyndon B. Profiling rTMS: A critical response. Aust N Z J Psychiatry 2021;55:355-65. [PMID: 33797287 DOI: 10.1177/00048674211006192] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
345 Munkholm K, Jørgensen KJ, Paludan-müller AS; Cochrane Common Mental Disorders Group. Electroconvulsive therapy for preventing relapse and recurrence in people with depression. Cochrane Database of Systematic Reviews 2022;2022. [DOI: 10.1002/14651858.cd015164] [Reference Citation Analysis]
346 Malhi GS, Byrow Y, Outhred T, Fritz K. Exclusion of overlapping symptoms in DSM-5 mixed features specifier: heuristic diagnostic and treatment implications. CNS Spectr 2017;22:126-33. [DOI: 10.1017/s1092852916000614] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
347 Boyce P, Ma C. Choosing an antidepressant. Aust Prescr 2021;44:12-5. [PMID: 33664544 DOI: 10.18773/austprescr.2020.064] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
348 Smith KA, Cipriani A. Lithium and suicide in mood disorders: Updated meta-review of the scientific literature. Bipolar Disord 2017;19:575-86. [DOI: 10.1111/bdi.12543] [Cited by in Crossref: 82] [Cited by in F6Publishing: 68] [Article Influence: 16.4] [Reference Citation Analysis]
349 Cebrino J, Portero de la Cruz S. Diet Quality and Sociodemographic, Lifestyle, and Health-Related Determinants among People with Depression in Spain: New Evidence from a Cross-Sectional Population-Based Study (2011-2017). Nutrients 2020;13:E106. [PMID: 33396825 DOI: 10.3390/nu13010106] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
350 Malhi GS, Gessler D, Fritz K, Allwang C, Outhred T, Das P. Recommendations in International Clinical Practice Guidelines for Lithium Therapy of Bipolar Disorder. In: Malhi GS, Masson M, Bellivier F, editors. The Science and Practice of Lithium Therapy. Cham: Springer International Publishing; 2017. pp. 189-209. [DOI: 10.1007/978-3-319-45923-3_11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
351 Gaynes BN, Lux L, Gartlehner G, Asher G, Forman-Hoffman V, Green J, Boland E, Weber RP, Randolph C, Bann C, Coker-Schwimmer E, Viswanathan M, Lohr KN. Defining treatment-resistant depression. Depress Anxiety 2020;37:134-45. [PMID: 31638723 DOI: 10.1002/da.22968] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 9.7] [Reference Citation Analysis]
352 Polacsek M, Boardman GH, McCann TV. A Theory on the Components of Depression Self-Management in Older Adults. Qual Health Res 2021;31:160-71. [PMID: 32996403 DOI: 10.1177/1049732320961060] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
353 Bai W, Liu ZH, Jiang YY, Zhang QE, Rao WW, Cheung T, Hall BJ, Xiang YT. Worldwide prevalence of suicidal ideation and suicide plan among people with schizophrenia: a meta-analysis and systematic review of epidemiological surveys. Transl Psychiatry 2021;11:552. [PMID: 34716297 DOI: 10.1038/s41398-021-01671-6] [Reference Citation Analysis]
354 Baune BT, Boyce P, Morris G, Hamilton A, Bassett D, Hopwood M, Mulder R, Parker G, Porter R, Singh AB, Outhred T, Das P, Malhi GS. Organising the front line: Is there a rationale for the first-line pharmacotherapy of major depressive disorder? Aust N Z J Psychiatry 2019;53:279-81. [PMID: 30813748 DOI: 10.1177/0004867418824026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
355 Ng VWS, Man KKC, Gao L, Chan EW, Lee EHM, Hayes JF, Wong ICK. Bipolar disorder prevalence and psychotropic medication utilisation in Hong Kong and the United Kingdom. Pharmacoepidemiol Drug Saf 2021. [PMID: 34180569 DOI: 10.1002/pds.5318] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
356 Hong RH, Murphy JK, Michalak EE, Chakrabarty T, Wang Z, Parikh SV, Culpepper L, Yatham LN, Lam RW, Chen J. Implementing Measurement-Based Care for Depression: Practical Solutions for Psychiatrists and Primary Care Physicians. Neuropsychiatr Dis Treat 2021;17:79-90. [PMID: 33469295 DOI: 10.2147/NDT.S283731] [Reference Citation Analysis]
357 Li B, Lv J, Wang W, Zhang D. Dietary magnesium and calcium intake and risk of depression in the general population: A meta-analysis. Aust N Z J Psychiatry 2017;51:219-29. [DOI: 10.1177/0004867416676895] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
358 McAulay C, Mond J, Outhred T, Malhi GS, Touyz S. Eating disorder features in bipolar disorder: clinical implications. J Ment Health 2021;:1-11. [PMID: 33573438 DOI: 10.1080/09638237.2021.1875401] [Reference Citation Analysis]
359 de Beer WA. Original opinion: the use of Bloom's Taxonomy to teach and assess the skill of the psychiatric formulation during vocational training. Australas Psychiatry 2017;25:514-9. [PMID: 28856918 DOI: 10.1177/1039856217726692] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
360 Plöderl M, Hengartner MP. Guidelines for the pharmacological acute treatment of major depression: conflicts with current evidence as demonstrated with the German S3-guidelines. BMC Psychiatry 2019;19:265. [PMID: 31477074 DOI: 10.1186/s12888-019-2230-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
361 Kim K, Yang H, Na E, Lee H, Jang OJ, Yoon HJ, Oh HS, Ham BJ, Park SC, Lin SK, Tan CH, Shinfuku N, Park YC. Examining Patterns of Polypharmacy in Bipolar Disorder: Findings from the REAP-BD, Korea. Psychiatry Investig 2019;16:397-402. [PMID: 31132844 DOI: 10.30773/pi.2019.02.26.4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
362 Worsley A, Smythe J, Kulkarni J. A case of perimenopausal depression. Aust N Z J Psychiatry 2016;50:1109. [PMID: 27698111 DOI: 10.1177/0004867416671597] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
363 Stephenson LA, Gergel T, Gieselmann A, Scholten M, Keene AR, Rifkin L, Owen G. Advance Decision Making in Bipolar: A Systematic Review. Front Psychiatry 2020;11:538107. [PMID: 33192654 DOI: 10.3389/fpsyt.2020.538107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
364 Jochim J, Rifkin-Zybutz RP, Geddes J, Cipriani A. Valproate for acute mania. Cochrane Database Syst Rev 2019;10:CD004052. [PMID: 31621892 DOI: 10.1002/14651858.CD004052.pub2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
365 Murray G. Adjunctive psychosocial interventions for bipolar disorder: Some psychotherapeutic context for the Canadian Network for Mood and Anxiety Treatments (CANMAT) & International Society for Bipolar Disorders (ISBD) guidelines. Bipolar Disord 2018;20:494-5. [DOI: 10.1111/bdi.12655] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
366 Cipriani A, Zhou X, Del Giovane C, Hetrick SE, Qin B, Whittington C, Coghill D, Zhang Y, Hazell P, Leucht S, Cuijpers P, Pu J, Cohen D, Ravindran AV, Liu Y, Michael KD, Yang L, Liu L, Xie P. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Lancet 2016;388:881-90. [PMID: 27289172 DOI: 10.1016/S0140-6736(16)30385-3] [Cited by in Crossref: 297] [Cited by in F6Publishing: 134] [Article Influence: 49.5] [Reference Citation Analysis]
367 Menkes D, Bosanac P, Castle D. MAOIs - does the evidence warrant their resurrection? Australas Psychiatry 2016;24:371-3. [PMID: 26917855 DOI: 10.1177/1039856216634824] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
368 Whiting DL, Chuah SL, Simpson GK, Deane FP, Reynolds J. Video-consulting to address mental health needs after traumatic brain injury: evaluation of a training workshop to build capacity among psychologists. Brain Inj 2021;:1-10. [PMID: 34334058 DOI: 10.1080/02699052.2021.1953594] [Reference Citation Analysis]
369 Pooja F, Chhabria P, Kumar P, Kalpana F, Kumar P, Iqbal A, Qamar Z, Khalid D, Rizwan A. Frequency of Psychiatric Disorders in Suicide Attempters: A Cross-Sectional Study from Low-Income Country. Cureus 2021;13:e14669. [PMID: 34079669 DOI: 10.7759/cureus.14669] [Reference Citation Analysis]
370 Tickell A, Ball S, Bernard P, Kuyken W, Marx R, Pack S, Strauss C, Sweeney T, Crane C. The Effectiveness of Mindfulness-Based Cognitive Therapy (MBCT) in Real-World Healthcare Services. Mindfulness (N Y) 2020;11:279-90. [PMID: 32064009 DOI: 10.1007/s12671-018-1087-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
371 Bassett D, Bear N, Nutt D, Hood S, Bassett S, Hans D. Reduced heart rate variability in remitted bipolar disorder and recurrent depression. Aust N Z J Psychiatry 2016;50:793-804. [DOI: 10.1177/0004867416652734] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
372 Eyre-watt B, Mahendran E, Suetani S, Firth J, Kisely S, Siskind D. The association between lithium in drinking water and neuropsychiatric outcomes: A systematic review and meta-analysis from across 2678 regions containing 113 million people. Aust N Z J Psychiatry 2021;55:139-52. [DOI: 10.1177/0004867420963740] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
373 Amare AT, Schubert KO, Hou L, Clark SR, Papiol S, Cearns M, Heilbronner U, Degenhardt F, Tekola-Ayele F, Hsu YH, Shekhtman T, Adli M, Akula N, Akiyama K, Ardau R, Arias B, Aubry JM, Backlund L, Bhattacharjee AK, Bellivier F, Benabarre A, Bengesser S, Biernacka JM, Birner A, Brichant-Petitjean C, Cervantes P, Chen HC, Chillotti C, Cichon S, Cruceanu C, Czerski PM, Dalkner N, Dayer A, Del Zompo M, DePaulo JR, Étain B, Jamain S, Falkai P, Forstner AJ, Frisen L, Frye MA, Fullerton JM, Gard S, Garnham JS, Goes FS, Grigoroiu-Serbanescu M, Grof P, Hashimoto R, Hauser J, Herms S, Hoffmann P, Hofmann A, Jiménez E, Kahn JP, Kassem L, Kuo PH, Kato T, Kelsoe JR, Kittel-Schneider S, Kliwicki S, König B, Kusumi I, Laje G, Landén M, Lavebratt C, Leboyer M, Leckband SG, Tortorella A, Manchia M, Martinsson L, McCarthy MJ, McElroy SL, Colom F, Mitjans M, Mondimore FM, Monteleone P, Nievergelt CM, Nöthen MM, Novák T, O'Donovan C, Ozaki N, Ösby U, Pfennig A, Potash JB, Reif A, Reininghaus E, Rouleau GA, Rybakowski JK, Schalling M, Schofield PR, Schweizer BW, Severino G, Shilling PD, Shimoda K, Simhandl C, Slaney CM, Squassina A, Stamm T, Stopkova P, Maj M, Turecki G, Vieta E, Veeh J, Witt SH, Wright A, Zandi PP, Mitchell PB, Bauer M, Alda M, Rietschel M, McMahon FJ, Schulze TG, Baune BT; Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium. Association of polygenic score for major depression with response to lithium in patients with bipolar disorder. Mol Psychiatry 2020. [PMID: 32203155 DOI: 10.1038/s41380-020-0689-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
374 Lande RG. Nutraceutical Augmentation Strategies for Depression: A Narrative Review. J Am Osteopath Assoc 2020;120:100-6. [PMID: 31985760 DOI: 10.7556/jaoa.2020.019] [Reference Citation Analysis]